In 1949, The Leukemia & Lymphoma Society (LLS) was founded on a dream, by parents who’d lost a son to acute lymphoblastic leukemia and sought to spare others their pain.
Since then, LLS has never stopped dreaming. Our bold achievements continue to push boundaries as we seek cutting edge treatments and cures and work to improve quality of life for patients and their families.
Our progress has been nothing short of astonishing. 2022 was no exception. Take a look...
In 2022, we:
... witnessed the FDA approval of 14 new blood cancer treatment options, many because of longstanding LLS support
... advanced promising blood cancer research worldwide by funding more than 117 scientists and investing in 17 Therapy Acceleration Program® (TAP) partners
… deepened our commitment to transform treatment and care for kids with the launch of The Dare to Dream Project launched our PedAL Master Clinical Trial to expedite safer, more targeted treatments for pediatric acute leukemia
... advanced health equity through multifaceted efforts across research, education & support, and advocacy efforts.
... increased financial assistance funding for patients and families, by nearly 60% compared to last year
... expanded offerings and increased education and support services for patients, survivors, families, and healthcare professionals
… advocated by raising the voices of blood cancer patients and their families leading to federal and local victories
continued to raise the bar on our fundraising efforts across our signature campaigns, corporate partnerships, and advancement efforts
With your help, we are creating a world where cancer patients not only survive their blood cancer but thrive in their lives after treatment
The evolution of new blood cancer therapies has been breathtaking—spanning the gamut from genetargeted therapies to cell-based immunotherapies— and providing remarkable benefit to patients.
The Leukemia & Lymphoma Society (LLS) is the largest nonprofit funder of blood cancer research, having invested more than $1.6 billion since our founding. In the last six years alone, we have helped advance more than 70% of the 110 (!) blood cancer treatment options approved by the U.S. Food and Drug Administration.
But LLS does more than fund pioneering research. We’re here to support patients and families through every part of their blood cancer experience— from diagnosis through treatment and beyond. We provide the reassurance, free personalized information and financial assistance they need. And we advocate for policies that break down barriers to care, so it’s more accessible and affordable for those in underserved communities.
At LLS, we envision a world without blood cancer. We work toward that dream every day and have made bold progress in our mission to cure blood cancers and improve the quality of life for patients and their families.
I am exceptionally proud of what we’ve accomplished together and excited about all that’s on the horizon.
Louis J. DeGennaro, PhD | President and Chief Executive Officer
In 2004, I was diagnosed with acute myeloid leukemia (AML) and given a 40% chance to live. I was one of the lucky survivors—thanks to pioneering scientists who created medicine that cured me. Once in remission, I resolved to do whatever I could to help blood cancer patients and to accelerate the development of new treatments so that more patients could survive these terrible blood cancers.
I searched for a nonprofit to support and found in LLS an organization that not only deploys its donations responsibly and effectively in service of patients but is transforming blood cancer treatment and care.
I’ve been fundraising and volunteering for LLS ever since—first as a member of the Georgia board, then as part of LLS’s national board, and now proudly as National Board Chair. I believe there’s no better use of our time and talents than helping others.
Your support has lifesaving and life-changing power. Through your generosity of heart and spirit, you are helping LLS ensure a future of expanded hope for all blood cancer patients and those who love and care for them.
I am grateful for you and the sacrifices you make to help others. Thank you.
Jeff Sachs | Chair of the Board
At LLS, our pediatric triumphs help make the case that dreams can come true. Cancers previously associated with nearly certain death are now highly survivable. Through our Children’s Initiative, we have supported breakthrough research, developed programs to support pediatric patients and families, and sparked interest among leading experts in pediatric oncology. But LLS knows there is more to accomplish, and in 2022, we deepened our commitment to further galvanize progress with the next phase of our Children's Initiative: The Dare to Dream Project. With an expanded vision, and a name that reflects our belief that this big, bold project is achievable, we are aiming higher than ever before: a total transformation of treatment for children with blood cancer through a 360-degree, holistic approach. With a five-year fundraising goal of $175M, our efforts are in full swing to...
LLS is committed to ensuring long-term quality-of-life for the youngest blood cancer patients. Our goal is to uncover less toxic individualized therapies that target cancer cells, spare healthy cells, and avoid adverse long-term health consequences. The 2022 launch of LLS’ Pediatric Acute Leukemia (PedAL) Master Clinical Trial marked a critical milestone in this quest. This unprecedented international collaborative effort between LLS, the National Cancer Institute (NCI), the Children’s Oncology Group (COG), and other partners and sponsors breaks new ground, bringing precision medicine to the treatment of pediatric relapsed acute leukemia
Rather than a “one size fits all” approach, PedAL uses genomics and other biomarkers to customize treatment, allowing innovative therapies to be matched to patients based on their unique tumor biology. A wide range of trial screening locations—spanning Europe, Australia, New Zealand, Canada, and over 200 U.S. sites—ensures widespread participation. Arkansas Children’s Hospital became the first U.S. therapeutic trial site in 2022, with more to come.
Two LLS-supported digital breakthroughs led by the University of Chicago are contributing to PedAL’s robust data infrastructure, allowing for standardized assessment of tumor biology and global data sharing:
• GEARBOx (Genomic Eligibility Algorithm at Relapse for Better Outcomes): a search tool that helps physicians match relapsed leukemia patients to available clinical trials
• Data Commons: a platform that ensures consistency in global data reporting, analysis, and access
“ Children have a unique disease with unique targets. Efforts like PedAL are critical to address the specific needs of our youngest, most vulnerable patients by using new, safer therapies. ”
— Dr. Todd Cooper, section chief of Pediatric Oncology; director of the Pediatric Leukemia/Lymphoma Program; co-director of the High-Risk Leukemia Program at Seattle Children’s; PedAL screening trial leadTHE Big Dream
To transform treatment and care for kids with blood cancer…so they not only survive but thrive in their lives after treatment.
When three-year-old Cayden Addison of Chesapeake, VA, was diagnosed with high-risk Philadelphia Chromosome-positive acute lymphoblastic leukemia (ALL), his mom Courtney “sobbed like never before.”
From that point forward, Courtney knew she’d embrace a dual mission: to learn all she could about blood cancer, while getting Cayden through the surgeries, chemotherapy, and countless overnight hospital stays he would need to endure. A recommendation from a friend connected the Addisons to LLS’ flagship Light The Night fundraising campaign and before long, Cayden was named the campaign’s 2021 National Honored Hero, serving as an LLS Ambassador of Hope. Involvement with LLS has provided needed support for Courtney during Cayden’s cancer journey. “Through LLS, I’ve learned there is a whole community of people out there who were just as passionate and dedicated to fighting this disease as I am.” Cayden finished treatment in April 2022, and Courtney has drawn hope and strength from a “brave, strong, resilient, and grateful” Cayden… and from LLS. Courtney now serves as a Dare to Dream Ambassador, sharing her family’s story to raise awareness about LLS and the need for better treatments.
“I know LLS’ great work is helping bring us closer to a world where no parent has to hear, ‘your child has cancer.’”
LLS seeks to improve our understanding of all pediatric blood cancers and develop better, safer treatments so as many patients as possible survive without lifelong health challenges. We have increased our pediatric research investment significantly, with a commitment to invest more than $52M in pediatric grants by 2027. In FY22 alone, our $8.4M commitment to pediatric blood cancer projects represented a four-fold increase compared to FY21. Like PedAL, all our laboratory research efforts explore therapeutics that consider the unique genetics of pediatric blood cancers and replace “one size fits all” chemotherapy with targeted treatments. We are funding over 30 pediatric-specific grants, including work focused on long-term side effects of treatment and improved relapse detection.
To provide 360-degree support for pediatric patients and families, we are expanding our educational resources and support services, with the emphasis on providing guidance, information, and comfort during treatments…and beyond. In 2022, we introduced our hardcover book trilogy, Stars Will Twinkle, The Sun Will Shine, available in English and Spanish, to educate pre-kindergarten children about a leukemia diagnosis—the first book in the U.S. to do so. Further, our Caregivers’ Guide to Navigating Childhood and Adolescent Blood Cancers, a digital “flip book” embedded with videos, was selected as a Gold Award Winner in the Spring 2022 Digital Health Awards. Additionally, we added specially trained pediatric nurse navigators to help families navigate the clinical trial process within our LLS Clinical Trial Support Center (CTSC).
For decades, LLS has fought to ensure access to affordable, quality healthcare for kids and young adults with blood cancer. Moreover, we’ve pushed to change outdated policies that stall pediatric drug development. In 2022, volunteer advocates and staff working closely with allies helped secure $160M in federal funds for pediatric cancer research nationwide. That funding was the result of hundreds of constituent meetings with lawmakers emphasizing the importance of those dollars for patients. LLS advocates also sent thousands of letters to lawmakers and held hundreds of meetings, resulting in Congress extending the Childhood Cancer STAR Act—the most comprehensive childhood cancer bill ever—for another five years.
40% of pediatric cancers are blood cancers
5% of cancer drugs have been approved for first-time use in children
80% of childhood cancer survivors develop chronic health issues from treatment
$ 233.8 MILLION
To discover breakthrough treatments and cures for all blood cancers and improve quality
LLS is the largest nonprofit funder of blood cancer research and has been instrumental in the development of nearly every breakthrough in its treatment. Because of LLS, blood cancers that were once fatal are now treatable and even curable.
LLS is proud of our role in advancing treatments that have exponentially improved survival rates and quality of life for patients with many types of blood cancer, but there is much more for us to accomplish.
LLS has a history of strategic investment in the most innovative and promising blood cancer research, leading to an unparalleled record of success. Today, blood cancer patients are living longer, better lives because LLS has supported generations of remarkable scientists leading to extraordinary advances. We put our support where it will make a real difference:
• Last year alone, LLS Research Grants supported 117 scientists at the world’s most prestigious institutions to advance next-generation approaches including immunotherapy, gene editing and precision medicine.
Halfway through a summer internship in Washington, D.C., Indiana resident William Yank was celebrating his 21st birthday when he started to feel “off.” Low energy and odd hand pains progressed to a sore throat and delirium, followed by a diagnosis of acute lymphoblastic leukemia (ALL). An accompanying infection led to septic shock and a potentially lethal cascade of symptoms as his organs were shutting down.
Transferred to Johns Hopkins Medical Center in Baltimore, William’s life was saved. “Through rigorous amounts of physical therapy, chemo, pain medication, and sheer will, I was able to leave a month and a half later,” William said. When additional chemotherapy proved insufficient to keep his cancer at bay, it was time for cutting edge CAR T-immunotherapy, which LLS helped fund. After one month back at Hopkins, remission was achieved. Sadly, six months later, William learned his cancer had returned, calling for another dose of CAR T cells.
Back in remission, William returned home for his senior year of college, but within months, his cancer was back. Another immunotherapy was used to prepare him for a stem cell transplant with his sister as donor. Now in long-term remission, William proudly advocates for other cancer and chronically ill patients through ‘The Illest’ cancer podcast which he created and co-hosts, and via TikTok videos.
• Therapy Acceleration Program® (TAP) is a unique venture philanthropy initiative partnering directly with biotechnology companies to invest in innovative therapies to change the standard of blood cancer care.
Since 2017, four TAP-supported therapies have been approved by the FDA or added to guidelines that drive treatment and insurance coverage decisions. Currently, there are more than 20 active clinical studies of TAP-supported therapies, including four that, if successful, will lead to additional new FDA approvals.
• The first of their kind LLS-Led Master Clinical Trials, Beat AML® and PedAL (Pediatric Acute Leukemia), have brought together a broad, global collaboration with some of the best and brightest industry leaders and academic institutions to fundamentally change treatment for adults and children.
Here are some highlights of how LLS is shaping the research landscape and the exciting work ongoing:
Immunotherapy harnesses the power of the immune system to attack cancer. LLS has invested more than $100 million in immunotherapy and our commitment is stronger than ever. Our early and sustained investment was vital to the development of CAR T-immunotherapy, which re-engineers a patient’s own immune T cells to fight their cancer.
With 12 approvals since 2017, and 4 in 2022 alone, CAR T is providing a lifeline for patients with acute lymphocytic leukemia, multiple myeloma and non-Hodgkin lymphomas. This year also saw approval of a first-in-class bispecific antibody to treat multiple myeloma. Bispecific antibodies attach to both tumor cells and immune T cells to activate them to attack the cancer.
Our ongoing investments are aimed at making immunotherapy available earlier in treatment and to patients with more types of blood cancer, shortening the time it takes to deliver CAR-T, and harnessing parts of the immune system beyond T cells to make treatments even better and longer lasting.
Blood cancer treatment has been revolutionized, thanks to precision medicine. By attacking cancer cells based on their unique genetic characteristics while leaving healthy cells alone, precision medicine helps to avoid short- and long-term side effects of conventional “one-size-fits-all” chemotherapies.
The FDA approved 13 new precision medicine treatments for blood cancers this year. We helped advance many of these new drugs and continue to invest in research to better understand the genetic underpinnings of blood cancer, discover new targets, and uncover new combination therapies. Through LLS’s Beat AML® and PedAL master clinical trials, LLS is unlocking the power of
While studying medicine in her native Egypt, and later for her PhD in Canada, Dr. Noha Sharafeldin sought to understand how certain factors— including genetics—make some people more susceptible to cancer. During her postdoctoral studies at the University of Alabama at Birmingham (UAB), her blood cancer outcomes and survivorship research caught the attention of LLS, earning her a Career Development Program (CDP) Special Fellow Award in 2018.
Dr. Sharafeldin credits LLS with “providing financial support and stability” that kept her “on track and focused” as she researched how to reduce long-term cognitive effects of bone marrow transplants on blood cancer survivors. “The CDP Fellow award was absolutely instrumental to my career,” she said, explaining that, besides funding, the recognition gave her “confidence…and the will to overcome challenges as an international scholar.”
Dr. Sharafeldin gives back to LLS as a member of her local LLS Students of the Year leadership team. Now an assistant professor of medicine at UAB and member of its Institute for Cancer Outcomes and Survivorship, she was recognized again in 2022, receiving the LLS-CDP Special Fellow Achievement Award. As one of four grantees honored as most impressive in the final year of their funding, Dr. Sharafeldin is hopeful that, as the survivor population grows, “efforts to reduce the negative impact on quality-of-life after cancer will be at the forefront,” adding that she will be “eternally grateful watching LLS move our field forward.”
precision medicine to transform treatment. PedAL launched this year (read more on page 2) while Beat AML,® launched in 2016, continues to generate strong results, showing superior survival rates and better quality of life when genomic analysis is used to match patients to gentler, targeted therapies.
Throughout the pandemic, the LLS National Patient Registry, a project of the Michael J. Garil Patient Data Collective, has generated essential information about the impact of COVID-19 and COVID-19 vaccines on the blood cancer community.
Our findings have helped patients and their families make informed vaccine and prevention choices and have shaped public policies designed to help them stay safer during this uniquely challenging time. Our current focus is on reporting critical data on breakthrough infections in blood cancer patients, including those who have received monoclonal antibodies to reduce the chances of COVID-19 infections.
The ability to intercept blood cancer at its earliest, most treatable stages, or even before it occurs, is becoming increasingly possible, thanks to high-powered genetic analysis that can identify patients with cancer-causing blood gene mutations.
Earlier this year, LLS-supported research reported that first responders to the World Trade Center attack on 9-11 have significantly higher rates of mutations in their blood associated with certain blood cancers, providing rationale for enhanced screening and prevention efforts for these heroes. With our support, an LLS advocate led an effort to secure an additional $1 million grant from New York State to help fund this project.
LLS is also funding a clinical study in Iceland to identify patients with an early precursor of multiple myeloma, known as MGUS (monoclonal gammopathy of undetermined significance), and follow their progression to myeloma. Iceland’s unique nationalized health system allows for tracking MGUS progression in a large population.
The ability to edit or replace defective genes is a promising new area for blood cancer discoveries and therapies. LLS is once again at the forefront by funding research using gene editing approaches to find new treatments and improve existing treatments. LLS TAP partner Caribou Biosciences, for example, is exploring using next-generation CRISPR genome-editing to eliminate a gene that shuts down T-cells, to hopefully sustain or even boost activity of CAR T cell treatment.
LLS HAS INVESTED MORE THAN IN RESEARCH FOR ALL TYPES OF BLOOD CANCER SINCE OUR FOUNDING
3 OF EVERY
LLS funds innovative research and researchers across the U.S. and the world who are working on better treatments for all types of blood cancer, including...
Omar Abdel-Wahab, MD Memorial Sloan Kettering Cancer Center
Developing new targeted therapies for every stage and subtype of hairy cell leukemia
Matteo Bellone, MD Fondazione Centro San Raffaele, Italy
Investigating whether a vaccine to modulate bacteria in the gut can block the progression of multiple myeloma to full-blown disease
Timothy Graubert, MD Massachusetts General Hospital
Building the foundational science needed to launch multiple clinical trials to test therapies for patients with mutations that make treatment more challenging
Richard Lock, PhD
The University of New South Wales, Australia
Testing a potential treatment for ALL, the most common pediatric blood cancer and one of the most common causes of death from disease in children
Julia Maxson, PhD Knight Cancer Institute, Oregon Health & Science University
Identifying multipronged strategies to improve outcomes for patients with myeloid cancers, such as AML and chronic neutrophilic leukemia
Catherine Smith, MD University of California, San Francisco
Working to identify the genetic mutations that can make acute myeloid leukemia resistant to conventional therapy, and developing novel treatment strategies
Srividya Swaminathan, PhD Beckman Research Institute of the City of Hope
Studying how cancer cells avoid immune system detection in children and adults with lymphoid malignancies including acute lymphoblastic leukemia and lymphomas
Ryan Wilcox, MD, PhD University of Michigan
Investigating a novel therapeutic target to treat an aggressive group of non-Hodgkin lymphomas called T-cell lymphomas
Acute Myeloid Leukemia with IDH1 mutation
Olutasidenib (Rezlidhia™)
Ivosidenib (Tibsovo®) in combination with azacitidine
Juvenile (Pediatric) Myelomonocytic Leukemia
Azacitidine (Vidaza®)
Multiple Myeloma
Relapsed/Refractory (advanced) disease
Teclistamab-cqyv (Tecvayli™) ■
Ciltacabtagene autoleucel (Carvykti™) ■
Follicular Lymphoma
Tisagenlecleucel (Kymriah®) ■ Mosunetuzumab (Lunsumio®) ■
Pediatric Classical Hodgkin Lymphoma
Brentuximab vedotin (Adcetris®) ■ in combination with chemotherapy
Large B-cell Lymphoma (second line treatment)
Lisocabtagene maraleucel (Breyanzi®) ■
Axicabtagene ciloleucel (Yescarta®) ■
Pediatric Graft Vs Host Disease
Ibrutinib (Imbruvica®)
Histiocytic Neoplasms
Cobimetinib (Cotellic®) ■
Myelofibrosis (high-risk primary or secondary)
Pacritinib (Vonjo™)
Myeloid/Lymphoid Neoplasms with FGFR1 mutation
Pemigatinib (Pemazyre®)
In 2022, two new treatments were approved to treat multiple myeloma—a CAR T-cell treatment in March and the first bispecific antibody in October. These approvals, both immunotherapy drugs, reinforce the long-term LLS strategy of investing in ways to activate the immune system to cure cancer. The new drugs take us one step closer to long-term control of multiple myeloma, but there is much more to do as we work towards a cure.
LLS has more than $31 million committed to more than 30 active laboratory and clinical research projects to improve the health and quality of life of patients with multiple myeloma. We search worldwide for the most innovative ideas, leading us to support a key clinical trial in Iceland that will lead to blocking the progression from pre-myeloma to myeloma. Additional work is focused on identifying mutations that cause the disease, and understanding why patients become resistant to certain treatments, and supporting clinical trials that will overcome resistance to currently approved immunotherapies.
With more than $93 million committed to leukemia research, LLS continues to lead the way toward cures, including with targeted therapies that zero in on specific genetic traits of cancer. We are working toward new standards of care, especially for children, that move away from toxic chemotherapies and toward precision approaches that target cancer cells without harming the rest of their bodies. Newly approved drugs this year for leukemia include a new treatment for a difficult and rare form of childhood leukemia that most often occurs in children before age 4, and a new targeted combination therapy for patients 75 and older with newly diagnosed AML with an IDH1 gene mutation.
Our growing knowledge is paving the way for newer, even more precise immunotherapy and precision medicine approaches, including an increasing number of CAR-T therapies, bispecific antibodies, and other immune-based therapies that can treat even more types of blood cancer and earlier in the course of the disease.
CAR T-cell therapies continue to redefine our approach to many types of lymphoma. As one of the earliest supporters of this groundbreaking immune-based approach, we were excited to see CAR T-therapies approved this year for use earlier in the treatment of large B-cell lymphoma and follicular lymphoma, offering patients a superior long-term remission rate compared to other therapies and the hope of a potential cure. Our work does not stop there. With $83 million dedicated to lymphoma research, we continue to push boundaries to find better and safer treatments for Hodgkin lymphoma and all forms of non-Hodgkin lymphoma. LLS has placed special emphasis on developing new therapies for mantle cell lymphoma, which includes the use of new precision medicines and therapies.
LLS proudly dedicates resources and expertise to research to improve the outlook for people with every type of blood cancer. Our efforts to identify and understand genetic mutations at work in blood cancer laid the foundation for 2022 drug approvals for patients with myeloproliferative neoplasms (MPNs) driven by mutations in genes called JAK2, IRAK1, CSFR1 and FGFR1. These gene names may sound like “alphabet soup,” but identifying these genes and developing drugs that target them is vital to affected patients. LLS has more than $30 million committed to research into MPNs and $26 million committed to improving our ability to diagnose, treat and stop myelodysplastic syndromes from progressing to acute leukemia. Our funding also played a key role in approval of a new precision medicine treatment to control histiocytic neoplasms. LLS funded key laboratory and clinical research leading to approvals for children and adults with this rare cancer.
At LLS, we recognize the financial and emotional impact a blood cancer diagnosis can have on patients and families. We also realize how difficult it is to navigate a complex healthcare system after diagnosis—especially given that there are many barriers to health equity. Our goal is to help ease these burdens by providing all-around support and advocacy for patients, survivors, caregivers, and families. In 2022, we made impressive headway.
LLS has a long-standing commitment to equity in blood cancer care. Guided by our fundamental belief that everyone deserves the best possible treatment, we have instituted multiple efforts to break down barriers and address the needs of underserved populations.
In 2022, we made meaningful progress as we…
To overcome disparities in health care, we must understand the obstacles. In 2022, we launched this signature program as part of our longstanding effort to understand barriers in blood cancer treatment and identify solutions to improve access to care. We granted over $1.3 million in combined funding for three teams of preeminent researchers, charged with uncovering the root causes of health disparities— information we can use to urge lawmakers and healthcare practitioners to affect positive change.
THE Big Dream
That all blood cancer patients—no matter who they are or where they live— receive the best care and support they need from diagnosis to treatment to survivorship.SHELLEY Hodgkin lymphoma survivor ALICE CLL survivor AINSLEY Hodgkin lymphoma survivor YOLANDA non-Hodgkin lymphoma survivor ZAINAB leukemia survivor PAUL multiple myeloma survivor
“ Blood cancer is hard enough for patients and their families, and obstacles make it even harder. We want to put an end to these disparities. That’s why LLS created the Equity in Access Research Program. ”
— Gwen Nichols, MD, LLS Chief Medical Officer
After receiving a leukemia diagnosis, Santa Clara County Deputy District Attorney Charles Huang’s best shot for survival was a bone marrow transplant. As an ethnic minority, Huang faced the heightened challenge of locating a “best match” donor from a similar ethnic background. His chances of finding an adult match with a donor of Asian descent, like himself, were estimated at 47%, versus 79% for Caucasian patients. While Huang’s brother was ultimately able to serve as his donor, he still dreamed of a way to ease the bone marrow matching process for other ethnic minorities.
From his hospital bed, Huang drafted what would become “Charlie’s Law”— legislation signed into law by California Gov. Gavin Newsom in 2022, enabling California residents to register for the National Marrow Donor Program when they apply for their driver’s licenses or ID cards.
He partnered with LLS—a leading advocacy organization with allies across California— to help pass the law. “Given the genetic diversity of California…this is going to save lives,” Huang said. Since the registry is national in scope, increasing the number of donors in California can benefit patients throughout the country. But it is Huang’s hope that other states will follow suit to further expand the number of registered donors—and the availability of lifesaving treatment—across the U.S.
To better serve the large and growing Hispanic population, we established a Latino Outreach Pilot program in the Greater Los Angeles and Central Valley areas of California. Input from local stakeholders, including patients, helped shape the pilot activities, including in-person and online Spanish-language programs. These initial efforts reached over 100,000 individuals affected by blood cancer, along with Promotores (community health workers), and healthcare providers. Evaluative data will guide the program's future expansion to more cities.
LLS believes that the full benefit of cancer research will not be realized until clinical trial participation better reflects the diversity of the U.S. population. We are dedicated to addressing barriers to clinical trial participation to accelerate scientific progress and to provide patients with access to novel therapies and approaches.
Our efforts ramped up in 2022, with the expansion of our LLS IMPACT (Influential Medicine Providing Access to Clinical Trials) Research Grants award. This program is designed to increase the enrollment of individuals from underrepresented communities in clinical trials. This year, we added three more grants expanding this “hub and spoke” model in six geographic locations across the country. The program now provides six “hubs” or major cancer centers with funding to set up networks of trial sites in local community-based hospitals and clinics with significant underserved populations.
Furthermore, we continued to provide financial support to ease the burden of trial participation, particularly for lower income patients and families.
LLS continued to take our messages to influential lawmakers who can advance policies that improve health equity. We are proud to have played a key role in securing:
• Passage of landmark clinical trial diversity reforms: LLS helped secure the passage of new policies that will enable more patients—including those from groups underrepresented in trials—to access trials. Trial sponsors will now be accountable for diversity targets, and patients should have access to trial services closer to home.
To move these efforts forward, we held a Virtual Day of Action, during which our advocates sent over 1,400 letters to Congress. LLS Board member Ruben Mesa, M.D. testified before a key congressional committee about the importance of trial diversity. In December, advocates met with nearly
100 Congressional offices to highlight the issue–just weeks before the U.S. House and Senate voted the changes into law.
• In-network access to cancer centers for Medicaid patients in New York and California. LLS advocacy was influential in the adoption of a New York law that will designate specialty cancer centers as “in-network” for millions who have health insurance through the marketplace or Medicaid. Our efforts also helped to drive passage of the California Cancer Care Equity Act, which gives the 13 million Californians covered by Medicaid access to specialty cancer centers, even if they’re not in-network. Both laws enhanced coverage through Medicaid which serves patients with lower incomes, and in both states, most patients covered by Medicaid are people of color.
More than $1.3 MILLION committed by LLS to enhance understanding of disparities in blood cancer care
More than 100,000 individuals with blood cancer reached by LLS’ inaugural Latino outreach efforts in California
Only 5-8% of blood cancer patients currently enroll in clinical trials; percentages even lower for underserved populations
79% bone marrow matching rate for Caucasian patients; 48% for Hispanics/Latinos; 47% for Asians; 29% for Blacks*
SIX MEDICAL CENTERS using LLS IMPACT grants to expand availability of clinical trials, up from three in 2021
More than 1,400 letters sent to Congress by LLS advocates on our Virtual Day of Action: 381 members of Congress reached
For more data on how LLS is driving forward health equity, scan here
The daughter of Ethiopian immigrants, Munira Nuru of Lees Summit, MO, has long possessed a special determination to succeed—a quality she attributes to her family’s unique history. Growing up in Addis Ababa, her parents were taught to value hard work and accomplishment, but were unable to attend college. During her own childhood, Munira’s parents “never failed to instill the value of education,” yet she knew money was tight. To reduce college costs, she took AP and dual-credit classes during high school. But a diagnosis of acute lymphoblastic leukemia (ALL) threw a curveball into her plans. “My concerns switched from trying to spare my parents the overwhelming cost of college to watching them struggle to pay for the medicine I needed to survive,” she said. Although Munira began her bachelor’s degree in biology at a low-cost community college, tuition became challenging when, after two years, she transferred to the University of Missouri, Kansas City. As a recipient of The Leukemia & Lymphoma Society’s Scholarship for Blood Cancer Survivors, she can now continue to pursue the degree she is “passionate about”—happy to show her parents that “all they taught me about hard work, grit, and the value of knowledge has finally paid off.”
The ever-rising cost of blood cancer care has left patients and families bearing the financial burden. LLS believes no patient should be denied treatment because they cannot afford it. Our financial assistance programs help overcome financial barriers so that patients can access the right care at the right time. This year, we significantly boosted our grants, providing more than $385 million in awards to more than 75,000 patients, up from $241 million to more than 42,000 patients last year.
We are helping young survivors achieve their educational goals, offering scholarships up to $7,500 for one year of higher education tuition. The 100 inaugural recipients spanned 34 states. Nearly one-fifth are first generation college students, and nearly half are studying science, health science, and nursing. Every year, we plan to award new recipients and renew eligible past awardees.
In the wake of the destruction caused by Hurricane Fiona and Hurricane Ian, LLS opened the LLS Financial Relief Fund to help blood cancer patients impacted by the storms in the FEMA designated disaster areas. Blood cancer patients living in declared disaster areas due to Hurricanes Fiona and Ian were eligible to receive a $250 pre-paid VISA card to help offset day-to-day expenses like food, clothing, housing, and gas.
2022 ASSISTANCE FROM OUR SIGNATURE PROGRAMS
Co-Pay Assistance Program
Helps cover costs for prescription drug insurance, plan premiums and co-pay obligations for specific diseases.
Scan here to see more in-depth information including ethnic, economic, and geographic data.
$371.5M IN ASSISTANCE
36,849 PATIENTS
Urgent Need Programs
Assists patients in acute financial distress with $500 for non-medical costs. In partnership with Moppie’s Love, Charlie’s Fund, and other generous donors.
Patient Aid Program
Provides a one-time stipend of $100 for any blood cancer patient with non-medical expenses.
Patient Travel Assistance Programs
Helps cover treatment-related transportation and lodging costs. Susan Lang Pay-It-Forward: $500 available every six months. Pre CAR-T-cell Therapy: $2,500 for patients under evaluation for CAR T-cell therapy. New: Multiple Myeloma Fund and the Pediatric Travel Fund.
11,763 PATIENTS $5.8M IN ASSISTANCE
$1.5M IN ASSISTANCE
15,405 PATIENTS
$6.5M IN ASSISTANCE
11,486 PATIENTS
“ One of the worst side-effects of fighting cancer is the cost of care. We are taking bold action to ensure that patients are not the only ones shouldering the rising cost of cancer care. ”
— Louis J. DeGennaro, PhD, LLS President and CEO
LLS is proud to be the leading “go to” source of free information and support for blood cancer patients, families, caregivers, and healthcare professionals. With an extensive array of services and materials, LLS provides essential guidance along the way from diagnosis, treatment to survivorship. This year, we increased outreach and support and expanded our innovative offerings.
LLS’s proprietary one-on-one oncology nutrition consultation service added a second registered dietician, allowing us to serve over 1,000 patients and caregivers throughout the year New resources include printed and online materials for patients and healthcare professionals to raise awareness of patient food insecurity and provide referral resources, and the first in an innovative series of online nutrition-education videos for pediatric cancer families.
To better serve those who have completed treatment, we issued numerous podcast episodes. A Conversation on Adult Survivorship, for healthcare professionals, had nearly 4,500 listens. Moreover, we released an online and print LLS Survivorship Workbook, used by over 13,000 individuals LLS Community, an online social network, created a new “Ask the Expert” series which reached almost 20,000 people and won a Bronze Award in the Spring 2022 Digital Health Awards.
“ Patients and their families often experience uncertainty and challenges, from diagnosis through survivorship. LLS is here to answer questions, address concerns, provide support, and foster hope.”
— Elisa Weiss, PhD, LLS Senior Vice President, Education, Services, & Health Research
Nearly 1,000 volunteers dedicated more than 26,000 hours to help LLS with outreach, information, and support for patients, families, and healthcare providers.
OUR FREE SIGNATURE SERIVCES
Information Resource Center
One-on-one information and support from highly trained oncology social workers and nurses.
Clinical Trial Support Center
Individualized assistance from nurse navigators to help patients enroll in trials.
Patient and Healthcare Professional Education
Education and resources for patients, caregivers, and healthcare professionals.
Patti Robinson Kaufmann
First Connection® Program
Peer-to-peer support that matches patients and caregivers with trained volunteers who experienced blood cancer.
APPROXIMATELY
26K
SPECIALIST-PATIENT INTERACTIONS
Scan here to find more data on the reach of our education and support services.
Myeloma Link
Outreach in Black communities to raise awareness and help patients access leading-edge care and resources.
NEARLY
22K PEOPLE REACHED
MORE THAN
1K PATIENTS ASSISTED
LLS Community Educational events featuring experts covering treatment options, breakthroughs, and survivorship issues.
MORE THAN
19K INDIVIDUALS HAVE JOINED
MORE THAN
500K BOOKLETS/FACT SHEETS DOWNLOADED OR ORDERED
MORE THAN
2K
PEER-TO-PEER CONNECTIONS MADE
Blood Cancer Conferences
Online community to chat, share experiences and provide support.
Personalized Nutrition Consultations
One-on-one sessions with registered dietitians with oncology expertise to help improve nutrition and manage treatment side effects.
12 CONFERENCES, REACHING 6,485 ATTENDEES
MORE THAN
1K PATIENTS/CAREGIVERS RECEIVED A NUTRITION CONSULTATION
Nothing is more important to a parent than their children's health. In August, 2019, Tim Heberlein of Tampa received word that his two-year old son, Remy, had Pre-B-cell acute lymphocytic leukemia (ALL). A tough three-year treatment journey ensued, including numerous rounds of
For decades, LLS has advocated by raising the voices of blood cancer patients and their families. At the heart of our efforts is a nationwide grassroots network of more than 200 volunteer advocacy leaders and 30,000 active online volunteers working hard to effect change. Together, we’ve made a tremendous impact.
30,000
For nearly a decade, LLS has urged lawmakers to limit outof-pocket drug costs for patients covered by Medicare, since many of those patients spend more than $10,000 a year on treatment. This year, LLS helped pass a transformative law that will cap Medicare beneficiaries’ out-of-pocket prescription drug costs at $2,000 annually. This will transform—and save—lives.
LLS-commissioned research has highlighted the critical role robust provider networks play in assuring patients’ access to timely care. This year, we helped secure a new federal rule requiring insurers to improve provider networks for plans sold through Healthcare.gov and other Affordable Care Act marketplaces. We also aided passage of a new federal policy requiring insurers to offer standardized health plans, including more affordable drug coverage, in the Affordable Care Act marketplaces. And thanks in part to our advocacy, millions of U.S. patients will now enjoy low- or no-cost health insurance premiums for coverage purchased through Healthcare.gov through at least 2025.
Thanks to our long-term advocacy, insurance plans will be required to charge an affordable, flat fee for prescription drugs, rather than a percentage of drug costs—a huge savings for those taking expensive specialty drugs. This marks LLS’ third state victory for better insurance coverage of costly drugs in the past three years alone.
We continued our efforts to influence federal regulations pertaining to implementation of the No Surprises Act (NSA), which ends surprise medical billing. Our involvement included filing legal briefs in numerous court cases dealing with attempts to unravel this Act and making sure states consider patient perspectives as they pass laws and rules related to these protections.
As a nationwide leader in the battle against “junk” insurance policies (that discriminate against those with cancer and other serious health conditions), we made headway in Kansas, helping to defeat a measure that would have expanded availability of these plans. Additional progress was made in Colorado, where we helped secure a law that will enable regulators to gather more information about these dangerous policies. We continue to advocate for stronger federal protections.
chemotherapy, but thankfully, in October 2022, Remy got to “ring the bell” signaling the end of his treatments. While his son’s treatments have ceased, Tim’s desire to fight for the rights of fellow blood cancer patients remains in full swing. In 2021, in the midst of Remy’s cancer battle, he was appointed the LLS Advocacy Leader in Florida. In this role, he leads a robust committee of advocacy volunteers responsible for helping advance the LLS Office of Public Policy’s (OPP) goals. Tim provides strategic direction, including identification of new advocacy volunteers, and helps develop advocates' skills so they, too, can effectively influence lawmakers to take action on issues critical to the blood cancer community. His invaluable 2022 contributions to LLS included building relationships with his members of Congress and their staff and urging them to take action on specific pediatric policy priorities. Tim accomplished this through visits in the district and virtually in Washington D.C. as part of LLS’s Lobby Day and the Alliance for Childhood Cancer Action Day.
If it sometimes takes a village to achieve one’s goals, LLS is fortunate to have such a community: the thousands of volunteers, donors, and corporate partners that, each year, help us raise the funds we need to conquer blood cancer.
In 2022, receding COVID-19 restrictions allowed us to begin transitioning back to in-person fundraising events, with great success. Participants across the globe crossed long-awaited finish lines, hit the slopes, hiked to new heights, and participated in virtual challenges…setting records in the process. The following LLS “village superstars” represent but a sampling of our dedicated supporters.
A Principal at WealthOne, LLC, Adam of Albany, NY, competed for LLS National MOTY, aiming for the highest total raised over a 10-week campaign. His mission was accomplished, bringing in $1,095,692 to support LLS. Adam’s participation was in honor of his friend and mentor, Todd Slingerland, who was diagnosed with an aggressive lymphoma in spring 2021. While Todd fortunately reached remission after several months of treatment, Adam’s drive was unabated. “Todd is a survivor today because of the investment, research, and support for which LLS tirelessly champions,” he said. “Just because Todd’s cancer is dormant, doesn't mean we can be— the fight continues, until we find a cure.”
After losing her mother, Eva Goldberg Lipman, to Hepatosplenic Gamma Delta T-cell lymphoma, a rare form of lymphoma in November 2020, Emily, owner of Emily Lipman Designs in Atlanta, turned her pain into passion by running for National WOTY. “I accepted this nomination knowing it would be difficult, but also I knew this was the way to honor my mother,” she said.
“[My mother] gave back in so many ways, and now it was my turn. No family should have to experience the devastation of cancer.”
Lipman Mahar’s record-setting $1,001,911 raised made her the first National WOTY to raise over $1 million in the campaign’s over 30-year history.
Three Atlanta high school juniors, all touched by blood cancer, formed “The Answer for Cancer” fundraising team. Leveraging their own musical talents to create an inspiring song video with over 1,000 YouTube views, they raised $559,366 for LLS— a record for the LLS Georgia-South Carolina Region. “As I got older, I became aware of the massive impact LLS's funding played in my cancer journey,” said Loughran, a 13-year leukemia survivor. Hight (18) participated to honor Loughran, and his grandmother, a non-Hodgkin lymphoma patient. And Voight (17) lent her singing voice in tribute to her cousin, Garland, diagnosed with Hodgkin lymphoma. “Why should our age limit us in galvanizing together with our communities so that one day, nobody has to hear the word ‘cancer’?” Voight said.
After learning he had cancer in February 2019, Marvin was “ready to battle and fight hard.” This Fayetteville, NC school superintendent and pastor took inspiration from Layla Smith, a second grade blood cancer survivor at one of his schools. “Her story encouraged me along my journey and is part of the ‘WHY’ I wanted to be involved with LLS,” he said. Fighting for “many more Laylas,” Marvin helped his district raise over $100,000 for LLS in the last two years, including $70K in FY22— with plans to raise an additional $60K for his 60th Birthday. Along with a group of district staff and students, Marvin attended his first in-person LTN event in Raleigh in October, honoring Layla. He called it “an amazing event… one of the highlights of my lifetime.”
Before learning of his own Chronic Lymphocytic Leukemia (CLL) diagnosis in 2013, John, an avid cyclist, marketing vice president, and current Chairman of the Board of Trustees for the Rocky Mountain Region, had participated in events that raised money for “virtually every charitable cause.” Once diagnosed, he joined LLS Team in Training (TNT) and formed Team Survivor, raising over $750,000 to LLS research. In his 2022 ride, his 9th, the Denver area resident journeyed with his team to Lake Tahoe and raised $125,000 to provide funding for a research portfolio—earning an LLS Impact Award in the process. “I will continue to ride for my friends who are in treatment and for those we have lost to this disease,” he stated, pledging he will “try to ride faster than Leukemia.”
In the summer of 2021, David and Heather Gentile of Haddon Twp, NJ, grew concerned over their two-year-old daughter Grace’s health. Multiple infections and uncharacteristically low energy led to various pediatrician appointments, a visit to the local ER, and a transfer to Philadelphia Children’s Hospital where doctors diagnosed B Cell Acute Lymphocytic Leukemia (ALL). Months of grueling treatments followed, including intensive chemotherapy, but by May 2022, Grace was placed on a maintenance treatment. That same month, the Gentile family participated in Big Climb Philadelphia, as part of the corporate team formed by David’s employer, Admiral Insurance—raising $13,740 for LLS’ mission Despite “bumps in the road,” David relayed that Grace, now in preschool, “continues to thrive, plays tots soccer, and has hopes of being a mermaid doctor when she grows up.”
Achievements Include:
Campaigns continue to grow, raising more than $172M
Direct to Consumer Campaigns grew by 11% raising nearly $45M
Advancement colleagues connected with donors in new ways, raising $66.2M
“Of the Year” mobilized community leaders and next-generation philanthropists to new revenue heights—with top fundraisers raising more than $1M
Light The Night was recognized as the number three peer-to-peer fundraising program in North America Thousands of Team In Training teammates came together for athletic events across the country raising more than $16M. Virtual event offerings continued to grow through the Resilience Challenge and Bike for Breakthroughs.
Light The Night:
Bryan Clementson, San Diego, CA, raised $250K+
Team in Training: Andrea Ferenchik, Cumming, GA, raised $171K+
National Man of the Year:
Adam Neary, Albany, NY, raised $1.095M
National Woman of the Year:
Emily Lipman Mahar, Atlanta, GA, raised $1M
National Visionary of the Year: Deborah Sturges, Fort Wayne, IN, raised $302K
National Man of the Year Runner-up: David Borowski, Ashburn, VA, raised $595K
National Woman of the Year Runner-up: Natasha del Barrio, Rio Grande Valley, TX, raised $840K
National Visionary of the Year Runner-Up: Richard Schwartz, Los Angeles, CA, raised $196K
National “All Star” Man of the Year: Matt Newsom, Charlotte, NC, raised $539K
National “All Star” Woman of the Year: Christine Mills, Washington, D.C., raised $133K
National “All Star” Visionary of the Year: Liz Sczudlo, Los Angeles, CA, raised $195K
National 2022 Students of the Year winners: “The Answer for Cancer”, Jordan Loughran, 18, Barrett Hight, 18, Alice Voigt, 17, Pace Academy, Atlanta, GA, raised $559K
2022 National Students of the Year runners-up: “Team Mission to Remission”, Katelyn Eberwein, 17, Charley Schumacher, 17, Sydney Yee, 17, Bishop Gorman High School, Las Vegas, NV, raised $537K
“ My brother Bobby died of leukemia on Christmas Day in 1951 at the age of 4, before I was born. For more than 40 years, my family and I have contributed to LLS, and by far the most meaningful impact we have made is through our support of LLS’s new book trilogy for pediatric patients and their families, entitled The Stars Will Twinkle, The Sun Will Shine My older brother Johnny was 7 when Bobby died; when Johnny read the trilogy, he said that having this resource would have made a world of difference for him and our family.”
“ As a current survivor of stage IV aggressive diffuse large b-cell non-Hodgkin lymphoma, I know firsthand how important it is to support LLS’s efforts. In fact, one of my curative measures was funded by LLS. Our family is honored to support Student Visionaries of the Year, Light the Night, and the Dare to Dream Project. I am not in control of the cancer coming back, but I AM in control of being positive, having faith over fear and making it my lifelong mission to give back and to support those who receive a cancer diagnosis.”
Many thanks to these companies who held steadfast in their commitment to LLS:
“ Despite many advances in blood cancer care and treatment, barriers exist in many communities to prevent patients from accessing new, more effective therapies and protocols that can lead to better outcomes. The gift awarded through Royalty Pharma’s alliance with The Leukemia & Lymphoma Society is intended to propel the work LLS is doing in underserved communities through three key initiatives that will help break down these barriers and ensure that everyone has access to the care they need to treat their blood cancer.”
As always, LLS gratefully thanks all of our dedicated volunteers and donors who help make our lifesaving work possible. Whether raising critical funds, advocating for lifesaving policies, providing support to those impacted by cancer, or building critical capacity, our donors, volunteers and supporters are invaluable as we continue to advance the LLS mission.
“ My wife Marcie and I first got involved with LLS following my diagnosis with Hodgkins lymphoma in 2017. I needed a stem cell transplant and was referred to the Information Resource Center for information on how to proceed with the treatment. Following my treatment and ultimate recovery, my entire family became very involved with LLS. I joined the Greater Los Angeles Board in 2019, where I currently serve as Board Chair. Our middle daughter, Samantha, was a Student of the Year candidate in 2021, our youngest daughter is on a team in 2022, and Marcie has been on the Visionary of the Year committee. Our family has gathered a large group of team participants for the past two Light the Nights and we have generously supported innovative research led by LLS in the pursuit of an ultimate cure for Hodgkins lymphoma.”
“ Since its inception in 1999, The Harry T. Mangurian, Jr. Foundation has built an ongoing partnership with The Leukemia & Lymphoma Society. While leukemia claimed the life of our founder, his legacy has lived on through the Foundation’s participation in the Beat AML Master Clinical Trial and the Children’s Initiative. Further, throughout our relationship, the transparency and stewardship provided by LLS to all of its supporters through interim and annual reporting has shown that exceptional progress has been realized through research, clinical trials and, most importantly, the saving of lives. We are proud to be a part of the team leading the fight to eradicate this disease.”
AbbVie Inc.
Amgen Inc.
BeiGene, Ltd.
Bristol Myers Squibb
Burlington
Eli Lilly and Company
Gateway for Cancer Research
Genentech Inc.
Gilead Sciences, Inc.
GSK (formerly known as GlaxoSmithKline)
Janssen Biotech
Jazz Pharmaceuticals
Kite, A Gilead Company
Pfizer Inc.
Pharmacyclics, An AbbVie Company & Janssen Biotech
Royalty Pharma
Subaru of America Inc.
Takeda Oncology
Walgreens
Wawa
2022 was a year of important transformation and significant milestones for LLS. We celebrate our achievements, but our work goes on and our dreams continue.
We will continue to pursue bold progress across all our mission priorities, until we realize our mission’s end goal: a world without blood cancers
Our priorities include…
One of the world’s leading funders and authorities on blood cancer research, LLS has contributed to nearly every new treatment in recent decades.
LLS is committed to making sure ALL blood cancer patients have access to and receive the treatment they need, regardless of location, race, language, or income.
LLS recognizes blood cancer patients have a lifelong journey to navigate and we are here for them, from diagnosis and treatment, through remission and beyond.
LLS is committed to relieving the financial burdens felt by patients who are coping with blood cancer through our Patient Financial Assistance Programs.
LLS is dedicated to helping patients access clinical trials to improve the care and treatment they receive for their specific blood cancer.
To give them their best chance for a cure and long-term quality of life, LLS is continually advocating to ensure all patients receive the best healthcare available.
Every step of the way, LLS is the leader in free information and comprehensive support for blood cancer patients, families, and healthcare professionals.
With The Dare to Dream Project, LLS is ushering in a new era of pediatric research, treatment, and care for children with cancer.
In fiscal year 2022, LLS raised $444 million to support our mission and operations. We spent $434 million—or 81% of our expenses—on specific programs designed to find new treatments for blood cancers, provide financial asssistance to blood cancer patients, break down barriers to care, and improve the lives of patients and their families.
Operations Makes the Mission Possible! Operational costs fuel the various ways LLS supports patients and families: from the free personalized assistance offered in our Information Resource Center and Clinical Trial Support Center; to podcasts, chats and opportunities to connect with others in our online community; to Virtual Blood
Conferences staffed with experts in the field.
GIVING IS PERSONAL.
Contributions don’t come from the wallet—they come from the heart. We respect how deeply our donors feel about what we do and why we do it.
GIVING IS COMMUNITY.
A shared passion for change unites us. No matter where we live or who we are, we are together as one for a common cause.
GIVING IS GOOD.
Our donors believe in sharing their resources willingly for the good of all, not just themselves.
GIVING IS HONEST.
We are always open about how, why, where, and when we use your contributions.
GIVING IS IMPACT.
We strive to make a meaningful difference in the lives of those around us and for those we may never meet.
Your generosity makes our work possible, and we promise to uphold your trust in us.
helps LLS do great work and it's getting noticed
LLS is proud to be recognized as a Fast Company 2022 Brand That Matters. LLS is the only cancer organization on the list and the only healthcare organization in the not-for-profit category.
LLS has a Four-Star Rating from Charity Navigator, America’s largest independent charity evaluator. This rating designates LLS as an official “Give with Confidence” charity, indicating that our organization is using its donations effectively.
The mission of The Leukemia & Lymphoma Society (LLS) is to cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. Find out more at www.LLS.org
LLS is dedicated to alleviating the burdens felt by patients coping with blood cancer. We work to ensure that patients are aware of all the services LLS has to offer and that no one is denied treatment because they cannot afford it. The LLS Patient Aid Program provides a one-time stipend of $100 to help offset expenses; there is no income criteria to qualify for the program.
More than 15,400 patients assisted
More than $1.5M in assistance awarded
PATIENTS IN 63% OF ALL U.S. COUNTIES
PATIENTS IN 30% OF THE MOST RURAL COUNTIES**
More than 60% of recipients have accessed other LLS financial assistance programs
Nearly 61% referred by a healthcare professional or facility
“ I live in Osprey, Florida and make frequent trips to Tampa. This is 90 minutes from our home. Needless to say, especially with the price of gas as it is right now, it is costly to make that drive back and forth. The $100 check I received will be used to offset the cost of gas. It has been very helpful and has made this difficult journey easier to navigate.
— Karen, Patient
PATIENTS IN 55% OF THE COUNTIES ACROSS THE U.S. WITH THE HIGHEST POVERTY RATES*
More than 13% were unemployed or retired
Of all the veterans assisted during FY22, 44% received Patient Aid awards
Patient Aid Assistance, by Race, as Identified by Patient
66% White
20% Black / African American
6% Other
4% Prefer not to disclose
2% Asian
1% American Indian / Native Alaskan
<1% Native Hawaiian / Pacific Islander
of Patient Aid recipients identified as Hispanic / Latino 13%
ROY multiple myeloma survivor CHARLES ALL survivor ZEENA Hodgkin lymphoma survivor ROBERT Hodgkin lymphoma survivor ZARIYAH ALL survivorWhen it comes to coping with blood cancer treatment, children, adolescents and their families and caregivers have a wide range of unique needs and challenges, which are unlike those of adults. The Urgent Need Pediatric, Adolescent and Young Adult Program, in partnership with Moppie’s Love, provides $500 in financial assistance to patients in acute financial need. The award covers non-medical expenses including housing, food, utilities, child/elder care, and other essentials.
More than 3,700 total patients assisted
More than $1.8M in assistance awarded
More than 69% of families report an annual income of $40,000 or less
Urgent Need Program, Pediatric, Adolescent and Young Adult awarded
PATIENTS IN 34% OF ALL U.S. COUNTIES
PATIENTS, OF WHOM 19% RESIDED IN MEDICALLY UNDERSERVED AREAS*
“ I wanted to reach out and say thank you so much for helping our family during this time! This has been such a hard time on us emotionally & financially. Since Jocelyn was diagnosed, I have not been able to work. With all the endless appointments and stress of just keeping it “together” for the family, going back to work brings me anxiety… I just wanted to say thank you so so much for helping our family financially during this time when inflation is out of hand. You are greatly appreciated! ”
PATIENTS IN 30% OF THE COUNTIES ACROSS THE U.S. WITH THE HIGHEST POVERTY RATES**
— Andrea, Jocelyn’s MotherUrgent Need Program, Pediatric, Adolescent and Young Adult Assistance, by Race, as Identified by Patient
58% White
22% Black / African American
9% Other
6% Prefer not to disclose
3% Asian
1% American Indian / Native Alaskan
<1% Native Hawaiian / Pacific Islander
of Urgent Need recipients identified as Hispanic / Latino 22%
The mission of The Leukemia & Lymphoma Society (LLS) is to cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. Find out more at www.LLS.org
ROY multiple myeloma survivor
CHARLES ALL survivor ZEENA Hodgkin lymphoma survivor
ROBERT Hodgkin lymphoma survivor
ZARIYAH ALL survivor
LLS is determined to break down barriers and help address the dilemma patients face when having to choose between paying for treatment or paying for their day-to-day living expenses. The Urgent Need Adult Program, in partnership with Charlie’s Fund, provides $500 in assistance to offset non-medical expenses including housing, food, utilities, child/elder care, etc.
8,050 total patients assisted
More than $4.0M in assistance awarded
More than 70% of recipients report an annual income of $40,000 or less
PATIENTS IN 49% OF ALL U.S. COUNTIES
PATIENTS, OF WHOM 19% RESIDED IN MEDICALLY UNDERSERVED AREAS*
More than 84% of recipients have accessed other LLS financial assistance programs
PATIENTS IN 45% OF THE COUNTIES ACROSS THE U.S. WITH THE HIGHEST POVERTY RATES**
“ I was not able to work and had almost no income during this time... LLS responded very quickly, sending us financial assistance through their Urgent Need Program. This assistance helped pay a propane heating invoice during a critical period in late winter. Cancer can be very difficult, but the financial assistance we received from LLS helped alleviate some of the financial stress that can accompany Lymphoma/ Leukemia treatments. We are very thankful for your help. ”
— Robert, Patient
Urgent Need Program, Adult Assistance, by Race, as Identified by Patient
64% White
25% Black / African American
4% Other
5% Prefer not to disclose
2% Asian
1% American Indian / Native Alaskan
<1% Native Hawaiian / Pacific Islander
of Urgent Need Adult recipients identified as Hispanic / Latino 9%
ROY multiple myeloma survivor CHARLES ALL survivor ZEENA Hodgkin lymphoma survivor ROBERT Hodgkin lymphoma survivor ZARIYAH ALL survivorRegardless of where patients live, transportation barriers are often cited as an obstacle to accessing care. Through the Susan Lang Pay-It-Forward Travel Assistance program, LLS provides financial assistance of $500 to help with treatment-related transportation and lodging.
More than 11,050 total patients assisted
More than $5.5M in assistance awarded
More than 66% of recipients report an annual income of $40,000 or less
Susan Lang Pay-It-Forward Travel Assistance Program awarded assistance to...
PATIENTS IN MORE THAN 53% OF ALL U.S. COUNTIES
PATIENTS, OF WHOM
19% RESIDED IN MEDICALLY UNDERSERVED AREAS*
“ Without this assistance there is no way I could have afforded filling my gas tank and my son’s (he drove me to the majority of my appointments when I wasn’t able). Thank you so much LLS, fighting cancer becomes much easier when not fighting gas prices and poverty.
— Scott,
Patient
Susan Lang Pay-It-Forward Travel Assistance, by Race, as Identified by Patient
PATIENTS IN
48% OF THE COUNTIES ACROSS THE U.S. WITH THE HIGHEST POVERTY RATES**
65% White
23% Black / African American
5% Other
3% Prefer not to disclose
2% Asian
1% American Indian / Native Alaskan
More than 93% of recipients have accessed other LLS financial assistance programs
79% of all patient expenses were fuel related
<1% Native Hawaiian / Pacific Islander
of Susan Lang Pay-It-Forward Travel Assistance recipients identified as Hispanic / Latino 10%
ROY multiple myeloma survivor CHARLES ALL survivor ZEENA Hodgkin lymphoma survivor ROBERT Hodgkin lymphoma survivor ZARIYAH ALL survivorTransportation and lodging are the largest out-of-pocket expense for patients during treatment weeks. LLS is addressing these barriers through its Susan Lang Pre CAR T-cell Therapy Travel Assistance program. The program provides $2,500 to patients who are being evaluated to receive CAR T-cell therapy as either standard treatment or a clinical trial. CAR T-cell therapy is a form of immunotherapy that uses specially altered T cells. The assistance covers the cost of treatment-related travel and lodging expenses for the patient and caregiver.
Pre CAR T-Cell Therapy Travel Assistance Program awarded assistance to..
MORE THAN
420 TOTAL PATIENTS ASSISTED
MORE THAN
$1.0M IN ASSISTANCE AWARDED
More than 83% were disabled, retired, or unemployed
Nearly 62% referred by a healthcare professional or facility
15% were being evaluated to participate in a Pre CAR T-cell therapy clinical trial
21% OF PATIENTS ASSISTED RESIDED IN MEDICALLY UNDERSERVED AREAS*
24% of all patient expenses were for lodging
More than 75% of recipients have accessed other LLS financial assistance programs
“ I live over an hour from the hospital, so the funds given to us by LLS will pay for rent for an apartment for one month, and the groceries and gas we will need to use while living away from our home. The funds provided will also allow for family to drive my two young children to and from the apartment to visit. Without the assistance program my husband and I would be unable to afford the necessary housing for this treatment to move forward.”
— ReNita, Patient
Pre CAR T-Cell Therapy Travel Assistance, By Race, As Identified By Patient
74% White
13% Black / African American
6% Other
4% Prefer not to disclose
2% Asian
1% American Indian / Native Alaskan
<1% Native Hawaiian / Pacific Islander
13%
of Pre Car T-Cell Therapy Travel Assistance recipients identified as Hispanic / Latino
ROY multiple myeloma survivor CHARLES ALL survivor ZEENA Hodgkin lymphoma survivor ROBERT Hodgkin lymphoma survivor ZARIYAH ALL survivorAt The Leukemia & Lymphoma Society (LLS), we are dedicated to alleviating the burdens felt by patients coping with blood cancer and we work to ensure that nobody is denied treatment because they cannot afford it. Our Co-Pay Program assists patients with the financial burden of treatment by paying for medical insurance premiums, treatment-related co-pays, deductibles, co-insurance, and prescription medication related to prescribed treatment.
More than 36,840 total patients assisted
More than $371M in assistance awarded
More than 51% of recipients report an annual income of $40,000 or less
PATIENTS IN MORE THAN 77% OF ALL U.S. COUNTIES
PATIENTS IN MORE THAN 52% OF THE MOST RURAL COUNTIES IN THE U.S.*
More than 380,000 patient claims paid
More than 175,000 calls received from patients, averaging 14,580 calls/month
PATIENTS IN 67% OF THE COUNTIES ACROSS THE U.S. WITH THE HIGHEST POVERTY RATES**
19% of patients resided in medically underserved areas†
Over 44% referred by a healthcare professional or facility and 25% referred by a pharmacy
“ LLS has helped me with my medical bills. At the time of my diagnosis I was in my last year as a special needs teacher assistant... I transitioned to Medicare. Medicare can be expensive when you’re on medication that is not offered in generic form. The assistance I get from LLS is so appreciated. I am so grateful. Thank you.
— Nancy, Patient
Co-Pay Assistance, by Race, as Identified by Patient
65% White
19% Prefer not to disclose
11% Black / African American
3% Other
1% Asian
<1% American Indian / Native Alaskan
<1% Native Hawaiian / Pacific Islander
of Co-Pay recipients identified as Hispanic / Latino 9%
ROY multiple myeloma survivor CHARLES ALL survivor ZEENA Hodgkin lymphoma survivor ROBERT Hodgkin lymphoma survivor ZARIYAH ALL survivor
The mission of The Leukemia & Lymphoma Society (LLS) is to cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. Find out more at www.LLS.org
ROY multiple myeloma survivor
CHARLES ALL survivor ZEENA Hodgkin lymphoma survivor
ROBERT Hodgkin lymphoma survivor
ZARIYAH ALL survivor
The mission of The Leukemia & Lymphoma Society (LLS) is to cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. Find out more at www.LLS.org
ROY multiple myeloma survivor
CHARLES ALL survivor ZEENA Hodgkin lymphoma survivor
ROBERT Hodgkin lymphoma survivor
ZARIYAH ALL survivor
LLS’S
PROGRAMS reached patients or caregivers in 82% of U.S. counties
A Caregiver’s Guide to Navigating Childhood and Adolescent Blood Cancers was selected as a Gold Award winner in the Spring 2022 Digital Health Awards®
County Reached County Not Reached
ROY multiple myeloma survivor
CHARLES ALL survivor ZEENA Hodgkin lymphoma survivor
ROBERT Hodgkin lymphoma survivor
ZARIYAH ALL survivor
ARYANNA non-Hodgkin lymphoma survivor
“ The assistance programs helped my family and I be able to have food and shelter.”
— Rebekah, a patient
33,900 ADCOVATES SENT MORE THAN LETTERS TO LAWMAKERS IN 2022
The mission of The Leukemia & Lymphoma Society (LLS) is to cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. Find out more at www.LLS.org
We may be dreamers, but we’re not the only ones.
The Leukemia & Lymphoma Society is forever grateful to the donors, volunteers, researchers, healthcare professionals, foundations, partners, sponsors, and philanthropic leaders across the country who stand with us, year after year, to help us Dream Big and Make Bold Progress.
Your ongoing generosity allows us to break new ground in research, patient support, advocacy, and fundraising.
We look forward to your continued partnership as we all dream of achieving.
The Specialized Center of Research program funds multidisciplinary research by teams of leading-edge academic investigators that hastens the discovery and development of better treatments for leukemia, lymphoma, and myeloma patients. A center is comprised of at least three independent research programs that are integrated and supported by scientific core laboratories.
Madhav Dhodapkar, MBBS, 2020 Emory University
Dr. Madhav Dhodapkar is funded in part by Emory University, Fred Hutchinson Cancer Research Center, and donations from The LIUNA Charitable Foundation.
Timothy Graubert, MD, 2022 Massachusetts General Hospital
Helen Heslop, MD, 2019 Baylor College of Medicine
Craig Jordan, PhD, 2019 University of Colorado Anschutz Medical Campus
Dr. Craig Jordan is jointly funded by the University of Colorado Anschutz Medical Campus and in part by a donation from Ron and Guadalupe Cohn.
Carl June, MD, 2020© Perelman School of Medicine at the University of Pennsylvania
Dr. Carl June is funded in part by a donation from the Higgins Family Foundation.
Jonathan Licht, MD, 2020 University of Florida
Tak Mak, PhD, 2023*
Princess Margaret Cancer Centre, University Health Network
Ari Melnick, MD, 2016
Weill Cornell Medicine
Dr. Ari Melnick is funded in part by Weill Cornell Medicine and a donation from the Mahoney family
Ari Melnick, MD, 2023*
Weill Cornell Medicine
Soheil Meshinchi, MD, PhD, 2022© Fred Hutchinson Cancer Research Center
Stephen Nimer, MD, 2018 University of Miami
Dr. Stephen Nimer is funded in part by donations from the Sylvester Comprehensive Cancer Center of the University of Miami.
Stephen Nimer, MD, 2023* University of Miami
Robert Soiffer, MD, 2023* Dana-Farber Cancer Institute
David Weinstock, MD, 2022 Dana-Farber Cancer Institute
Dr. David Weinstock is funded in part by Dana-Farber Cancer Institute.
The Career Development Program provides stipends to investigators of exceptional promise in the early stages of their careers, helping them devote their careers to research in leukemia, lymphoma, or myeloma.
The Career Development Program is supported in part by a donation from Paul Leinwand.
Arash Alizadeh, MD, PhD, 2020 Stanford University
Dr. Arash Alizadeh is funded in part by a donation from the Borstein Family Foundation.
Philippe Armand, MD, PhD, 2019
Dana-Farber Cancer Institute
Luca Busino, PhD, 2023*
Perelman School of Medicine at the University of Pennsylvania
Jason Butler, PhD, 2019
Hackensack Meridian Health
Grant Challen, PhD, 2019 Washington University in St. Louis
Jaehyuk Choi, MD, PhD, 2022 Northwestern University
Simona Colla, PhD, 2019 The University of Texas MD Anderson Cancer Center
Leslie Crews, PhD, 2023* University of California, San Diego
Alexey Danilov, MD, PhD, 2019 Beckman Research Institute of City of Hope
Dr. Alexey Danilov is funded in part by a donation from the Margaret and Foster Madeley Family Foundation.
Matthew Davids, MD, 2019 Dana-Farber Cancer Institute
Dr. Matthew Davids is jointly funded by Dana-Farber Cancer Institute and a donation from the Oxley Household.
Courtney DiNardo, MD, 2023*
The University of Texas MD Anderson Cancer Center
Dr. Courtney DiNardo is funded in part by a donation from the Gordon Charter Foundation.
Lei Ding, PhD, 2020 Columbia University Irving Medical Center
Areej El-Jawahri, MD, 2020 Massachusetts General Hospital
Maria Figueroa, MD, 2019 University of Miami
Alfred Garfall, MD, 2020 Perelman School of Medicine at the University of Pennsylvania
Michael Green, PhD, 2021
The University of Texas MD Anderson Cancer Center
Dr. Michael Green is jointly funded by The University of Texas MD Anderson Cancer Center.
Daniel Herranz, PhD, 2023* Rutgers University
Alex Herrera, MD, 2019
Beckman Research Institute of City of Hope
Dr. Alex Herrera is fully funded by a donation from Toni and Emmet Stephenson.
Keisuke Ito, MD, PhD, 2019
Albert Einstein College of Medicine
Caron Jacobson, MD, 2023*
Dana-Farber Cancer Institute
Dr. Caron Jacobson is funded in part by a donation from the Morgan Stanley Gift Fund.
Nitin Jain, MD, 2023*
The University of Texas MD
Anderson Cancer Center
Hao Jiang, PhD, 2019
University of Virginia
Alex Kentsis, MD, PhD, 2020© Memorial Sloan Kettering Cancer Center
Sigurður Kristinsson, MD, PhD, 2023*
University of Iceland
Dan Landau, MD, PhD, 2022
Weill Cornell Medicine
Andrew Lane, MD, PhD, 2023*
Dana-Farber Cancer Institute
Thomas LeBlanc, MD, MA, MHS, FAAHPM, 2023*
Duke University
Kasey Leger, MD, 2020© Seattle Children’s Hopsital
Coleman Lindsley, MD, PhD, 2023*
Dana-Farber Cancer Institute
Frederick Locke, MD, 2022
H. Lee Moffitt Cancer Center & Research Institute
Dr. Frederick Locke is jointly funded by H. Lee Moffitt Cancer Center & Research Institute and a donation from Net Lease Capital Advisors.
Rong Lu, PhD, 2020
University of Southern California
Dr. Rong Lu is jointly funded by University of Southern Califormia.
Daniel Lucas, PhD, 2023*
Cincinnati Children’s Hospital Medical Center
Jeffrey Magee, MD, PhD, 2022© Washington University School of Medicine in St. Louis
Julia Maxson, PhD, 2023*
Oregon Health & Science University Cancer Institute
Shannon McKinney-Freeman, PhD, 2019
St. Jude Children’s Research Hospital
Megan McNerney, MD, PhD, 2023*
The University of Chicago
Neha Mehta-Shah, MD, 2023* Washington University School of Medicine in St. Louis
Alison Moskowitz, MD, 2020 Memorial Sloan Kettering Cancer Center
Daisuke Nakada, PhD, 2020 Baylor College of Medicine
Lakshmi Nayak, MD, 2019
Dana-Farber Cancer Institute
Adam Olszewski, PhD, 2023* Rhode Island Hospital
Dr. Adam Olszewski fully funded by a donation from the Institute for Follicular Lymphoma.
Eirini Papapetrou, MD, PhD, 2019 Icahn School of Medicine at Mount Sinai
Tycel Phillips, MD, 2023* Beckman Research Institute of City of Hope
Daniel Pollyea, MD, 2020 University of Colorado Anschutz Medical Campus
Dr. Daniel Pollyea is funded in part by a donation from Ron and Guadalupe Cohn.
Zhijian Qian, PhD, 2019 University of Florida
Christiane Querfeld, MD, PhD, 2019 Beckman Research Institute of City of Hope
Dr. Christiane Querfeld is fully funded by a donation from the Schwartz Ward Family Foundation.
Kerry Rogers, MD, 2020
The Ohio State University
Dr. Kerry Rogers is funded in part by a donation from the Peters Household.
Rizwan Romee, MD, 2022
Dana-Farber Cancer Institute
Michael Savona, MD, 2019 Vanderbilt University Medical Center
Nirav Shah, MD, 2023* Medical College of Wisconsin
Catherine Smith, MD, 2023* University of California, San Francisco
Paolo Strati, MD, 2023*
The University of Texas MD Anderson Cancer Center
Koichi Takahashi, MD, 2023*
The University of Texas MD Anderson Cancer Center
Sarah Tasian, MD, 2023*©
The Children’s Hospital of Philadelphia
Dr. Sarah Tasian is funded in part by a donation from Jeanne Hubbard.
Jennifer Trowbridge, PhD, 2021
The Jackson Laboratory
Dr. Jennifer Trowbridge is jointly funded by The Jackson Laboratory.
G. Greg Wang, PhD, 2019
The University of North Carolina at Chapel Hill
Hong Wen, PhD, 2023*© Van Andel Research Institute
Jennifer Woyach, MD, 2022
The Ohio State University
Dr. Jennifer Woyach is jointly funded by The Ohio State University and donations from the Cora and John H. Davis Foundation and Schwab Charitable.
Jian Xu, PhD, 2020
Children’s Medical Center Research Institute at UT Southwestern
Yibin Yang, PhD, 2023* Institute for Cancer Research d/b/a
The Research Institute of Fox Chase Cancer Center
Jianhua Yu, PhD, 2019
The Ohio State University/Beckman Research Institute of City of Hope
Dr. Jianhua Yu is fully funded by a donation from the Schwartz Ward Family Foundation.
Amer Zeidan, MBBS, 2019 Yale University
Dr. Amer Zeidan is jointly funded by Yale University.
Robert Albero Gallego, PhD, 2020© Columbia University Irving Medical Center
Jeremy Baeten, PhD, 2023* Washington University in St. Louis
Christopher Booth, PhD, 2023* Dana-Farber Cancer Institute
Sisi Chen, PhD, 2023* Memorial Sloan Kettering Cancer Center
Christina Glytsou, PhD, 2022 New York University School of Medicine
Mark Hamilton, MD, PhD, 2023* Stanford University
Jonas Jutzi, MD, PhD, 2023*
Brigham and Women’s Hospital
Thomas Koehnke, MD, 2022 Stanford University
Frederike Kramer, PhD, 2023*
Brigham and Women’s Hospital
Rajni Kumari, PhD, 2022 Albert Einstein College of Medicine
Dr. Rajni Kumari is jointly funded by Albert Einstein College of Medicine.
Qingyu Luo, PhD, 2023* Dana-Farber Cancer Institute
Johanna Melo-Cardenas, PhD, 2021 St. Jude Children’s Research Hospital
Dr. Johanna Melo-Cardenas is fully funded by The Mark Foundation for Cancer Research.
Eugenio Morelli, MD, 2023*
Dana-Farber Cancer Institute
Homa Rahnamoun, PhD, 2023*
Dana-Farber Cancer Institute
Clara Reglero, PhD, 2023*© Columbia University Irving Medical Center
Dr. Clara Reglero is funded in part by a donation from The Salah Foundation.
Christopher Reilly, MD, 2023*
Dana-Farber Cancer Institute
Caner Saygin, MD, 2023*© The University of Chicago
Sylvain Simon, PhD, 2021 Fred Hutchinson Cancer Research Center
Dr. Sylvain Simon is fully funded by The Mark Foundation for Cancer Research.
Amin Sobh, PhD, 2023* University of Florida
Nathan Ungerleider, PhD, 2023*© Tulane University School of Medicine
Dane Vassiliadis, PhD, 2023* The University of Melbourne
Therese Vu, PhD, 2021© University of Colorado Anschutz Medical Campus
Dr. Therese Vu is fully funded by The Mark Foundation for Cancer Research and the Sebastian Positivity Foundation.
Elvin Wagenblast, PhD, 2022© Princess Margaret Cancer Centre, University Health Network /Icahn School of Medicine at Mount Sinai Dr. Elvin Wagenblast is funded in part by the Leukemia & Lymphoma Society of Canada.
The Translational Research Program supports outstanding investigators deemed by our expert advisors most likely to translate basic biomedical discoveries into new, safe, and effective treatments, ultimately prolonging and enhancing patients’ lives.
Iannis Aifantis, PhD, 2020© New York University School of Medicine
Wendy Béguelin, PhD, 2023* Weill Cornell Medicine
Matteo Bellone, MD, 2022
Fondazione Centro San Raffaele
Ravi Bhatia, MD, 2023*
The University of Alabama at Birmingham
Catherine Bollard, MD, 2023*
Children’s Research Institute
Grant Challen, PhD, 2023*
Washington University School of Medicine in St. Louis
Riccardo Dalla Favera, MD, 2023* Columbia University Irving Medical Center
Brian Dalton, MD, PhD, 2023* Johns Hopkins University
Randall Davis, MD, 2023*
The University of Alabama at Birmingham
Courtney DiNardo, MD, 2023*
The University of Texas MD Anderson Cancer Center
Gianpietro Dotti, MD, 2022
The University of North Carolina at Chapel Hill
Ann-Kathrin Eisfeld, MD, 2023*© The Ohio State University
Lucas Ferrari De Andrade, PhD, 2023*
Icahn School of Medicine at Mount Sinai
Terry Fry, MD, 2020 University of Colorado, Denver
Dr. Terry Fry is funded in part by a donation from the Don and Lorraine Freeberg Foundation.
Alfred Garfall, MD, 2023*
Perelman School of Medicine at the University of Pennsylvania
Jolanta Grembecka, PhD, 2023*© University of Michigan
Nitin Jain, MD, 2023*
The University of Texas MD Anderson Cancer Center
Ricky Johnstone, PhD, 2020
The University of Melbourne
Dr. Ricky Johnstone is jointly funded by Snowdome Foundation and Leukaemia Foundation of Australia.
Ricky Johnstone, PhD, 2023*
The University of Melbourne
Lev Kats, PhD, 2023*
The University of Melbourne
Dr. Lev Kats is jointly funded by Snowdome Foundation and Leukaemia Foundation of Australia.
Suzanne Lentzsch, MD, PhD, 2023* Columbia University Irving Medical Center
Jonathan Licht, MD, 2023* University of Florida
Richard Lock, PhD, 2023*© The University of New South Wales (UNSW)
Dr. Richard Lock is jointly funded by Snowdome Foundation and Leukaemia Foundation of Australia.
Jaroslaw Maciejewski, MD, PhD, 2023*
Cleveland Clinic Foundation
Ivan Maillard, MD, PhD, 2020 Perelman School of Medicine at the University of Pennsylvania
Dr. Ivan Maillard is funded in part by a donation from Taki Donovan.
Ravindra Majeti, MD, PhD, 2021 Stanford University
Dr. Ravindra Majeti is jointly funded by Snowdome Foundation and Leukaemia Foundation of Australia.
Charles Mullighan, MD, 2020 St. Jude Children’s Research Hospital
Dr. Charles Mullighan is jointly funded by Snowdome Foundation and Leukaemia Foundation of Australia.
Markus Muschen, MD, PhD, 2023* Yale University
Nicolas Nassar, PhD, 2023*© Cincinnati Children’s Hospital Medical Center
Stephen Nutt, PhD, 2020 Walter and Eliza Hall Institute of Medical Research
Dr. Stephen Nutt is jointly funded by Snowdome Foundation and Leukaemia Foundation of Australia.
Stephen Oh, MD, PhD, 2023* Washington University in St. Louis
Jane Oliaro, PhD, 2023*
The University of Melbourne
Dr. Jane Oliaro is jointly funded by Snowdome Foundation and Leukaemia Foundation of Australia.
Bruno Paiva, PhD, 2023* Universidad de Navarra
Suman Paul, MD, PhD, 2023* The Johns Hopkins University School of Medicine
John Pimanda, PhD, 2021
The University of New South Wales
Dr. John Pimanda is jointly funded by Snowdome Foundation and Leukaemia Foundation of Australia.
Christopher Porter, MD, 2023* Emory University
Noemi Puig Moron, MD, 2023* Institute of Biomedical Research from Salamanca
Aileen Rowan, PhD, 2023* Imperial College, University of London
Marco Ruella, MD, 2023* Perelman School of Medicine at the University of Pennsylvania
Kirk Schultz, MD, 2023* University of British Columbia
Dr. Kirk Schultz is jointly funded by the Leukemia & Lymphoma Society of Canada.
Mala Shanmugam, PhD, 2023* Emory University
Tomasz Skorski, MD, PhD, DSc, 2022 Temple University
Christian Steidl, MD, 2023* BC Cancer, part of the Provincial Health Services Authority
Dr. Christian Steidl is jointly funded by the Leukemia & Lymphoma Society of Canada.
Srividya Swaminathan, PhD, 2022© Beckman Research Institute of City of Hope
Dr. Srividya Swaminathan is jointly funded by Beckman Research Institute of City of Hope.
Daniel Thomas, PhD, 2023* The University of Adelaide
Ashwin Unnikrishnan, PhD, 2020
The University of New South Wales Dr. Ashwin Unnikrishnan is jointly funded by Snowdome Foundation and Leukaemia Foundation of Australia.
Ryan Wilcox, MD, PhD, 2023* University of Michigan
Joachim Yahalom, MD, FACR, 2023* Memorial Sloan Kettering Cancer Center
Roberta Zappasodi, PhD, 2023* Weill Cornell Medicine
Alex Zhang, PhD, 2022
The University of Texas Southwestern Medical Center
Carl Allen, MD, PhD, 2023*© Baylor College of Medicine
Alexey Danilov, MD, PhD, 2023* Beckman Research Institute of City of Hope
Timothy Ley, MD, 2022 Washington University School of Medicine in St. Louis
Kathleen Sakamoto, MD, PhD, 2023*© Stanford University
This program is run in partnership with the Mark Foundation for Cancer Research (MFCR) and The Paul G. Allen Frontiers Group (PAFG) to support groundbreaking early-stage research aimed to advance the treatment and cure of blood cancers and potentially other cancers as well.
Robert Bradley, MD, 2021 Fred Hutchinson Cancer Research Center
Dr. Robert Bradley is also funded in part by a donation from Todd Hanna.
Catriona Jamieson, MD, PhD, 2021 University of California, San Diego
Ronald Levy, MD, 2021 Stanford University
Ravindra Majeti, MD, PhD, 2021 Stanford University
Markus Muschen, MD, PhD, 2021 Yale University
Dr. Markus Muschen is also funded in part by a donation from Laurie Burns.
Susan Schwab, PhD, 2021© New York University School of Medicine
Margaret Shipp, MD, 2021
Dana-Farber Cancer Institute
Dr. Margaret Shipp is also funded in part by a donation from the TallenKane Foundation.
Robert Signer, PhD, 2021 University of California, San Diego
Daniel Starczynowski, PhD, 2021 Cincinnati Children’s Hospital Medical Center
This program supports groundbreaking early-stage research aimed to advance the treatment and cure of blood cancers and potentially other cancers as well.
Saar Gill, PhD, MBBS, 2023*
Perelman School of Medicine at the University of Pennsylvania
Lucy Godley, MD, PhD, 2023* The University of Chicago
Siddhartha Jaiswal, MD, PhD, 2023* Stanford University
Courtney Jones, PhD, 2023*
Princess Margaret Cancer Centre, University Health Network
Michael Kharas, PhD, 2023* Memorial Sloan Kettering Cancer Center
Peter Klein, MD, PhD, 2023* Perelman School of Medicine at the University of Pennsylvania
Ari Melnick, MD, 2023* Weill Cornell Medicine
Eirini Papapetrou, MD, PhD, 2023* Icahn School of Medicine at Mount Sinai
Jun Qi, PhD, 2023* Dana-Farber Cancer Institute
The IMPACT Program intends to expand access to high-quality clinical trials to patients by bringing the trials to the patients at their local community oncology centers.
The IMPACT Program is funded in part by donations from Bristol Myers Squibb, Eli Lilly and Company, MorphoSys Foundation and Royalty Pharma.
Christopher Flowers, MD, 2023* The University of Texas MD Anderson Cancer Center
John Leonard, MD, 2022 Weill Cornell Medicine
Dr. John Leonard is also jointly funded by Weill Cornell Medicine and donations from Jim Reddoch and the Wagner Household.
Gregory Nowakowski, MD, 2022 Mayo Clinic, Rochester
Dr. Gregory Nowakowski is also jointly funded by Mayo Clinic, Rochester and donations from Amy and Gentry Lee, John and Louise Bryan, and Cal Turner, Jr.
Michael Savona, MD, 2022 Vanderbilt University Medical Center Dr. Michael Savona is also jointly funded by Vanderbilt University Medical Center.
Tanya Siddiqi, MD, 2023* City of Hope National Medical Center
Clayton Smith, MD, 2023* University of Colorado Anschutz Medical Campus
This program is run in partnership to advance breakthroughs in prevention of blood cancers.
Liran Shlush, MD, PhD, 2019 Weizmann Institute of Science
Dr. Liran Shlush is also funded by donations from the Wrobel Family Foundation.
George Vassiliou, MD, PhD 2019 Wellcome Trust Sanger Institute/ University of Cambridge
This program is run in partnership with the Hairy Cell Leukemia Foundation to expand research in hairy cell leukemia to better characterize its biology, develop new therapies, and optimize outcomes for patients.
Omar Abdel-Wahab, MD, 2023* Memorial Sloan Kettering Cancer Center
Thomas Kipps, MD, PhD, 2023* University of California, San Diego Reshmi Parameswaran, PhD, 2023* Case Western Reserve University
David Ritchie, PhD, MBBS, 2023* Melbourne Health
Marco Ruella, MD, 2023*
Perelman School of Medicine at the University of Pennsylvania
Marc Seifert, PhD, 2023* Institute of Cell Biology (Tumor Research) at the Medical School Essen
Enrico Tiacci, MD, 2023* University of Perugia
Thorsten Zenz, MD, 2023* Universitätsspital Zürich - Klinik für Medizinische Onkologie und Hämatologie USZ
The Mantle Cell Lymphoma Research Initiative supports teams of researchers representing different disciplines and engaged in collaborative efforts to discover new approaches to treat patients with blood cancers.
The Mantle Cell Lymphoma Research Initiative is funded in part by donations from the Creel Household, the Fulenwilder Household, and the McGuire Household.
Selina Chen-Kiang, PhD, 2019 Weill Cornell Medicine
Dr. Selina Chen-Kiang is also funded by a donation from Sarah Cannon Research Institute.
Larry Kwak, MD, PhD 2019 Beckman Research Institute of City of Hope
Dr. Larry Kwak is funded by a donation from Sarah Cannon Research Institute.
This program is run in partnership with the MPN Research Foundation.
Iannis Aifantis, PhD, 2023* New York University School of Medicine
Idoroenyi Amanam, MD, 2023* Beckman Research Institute of City of Hope
Najla Arshad, PhD, 2023* Yale University
Michal Bar-Natan, MD, 2023* Icahn School of Medicine at Mount Sinai
Joan Beckman, MD, PhD, 2023* University of Minnesota
John Crispino, PhD, MBA, 2023* St. Jude Children’s Research Hospital
Shannon Elf, PhD, 2023* The University of Chicago
Sahand Hormoz, PhD, 2023* Dana-Farber Cancer Institute
Nicole Kucine, MD, MS, 2023* Weill Cornell Medicine
Shinobu Matsuura, DVM, PhD, 2023* Boston University School of Medicine
Joseph Michael Scandura, MD, PhD, 2023* Weill Cornell Medicine
This program is run in partnership with the International Waldenström’s Macroglobulinemia Foundation (IWMF).
Gareth Morgan, MD, PhD, FRCPath, FRCP, 2023*
New York University School of Medicine
Todd Cooper, DO, 2023*© Seattle Children’s Hospital
Charles Mullighan, MD, 2022© St. Jude Children’s Research Hospital
Kimberly Stegmaier, MD, 2021
Dana-Farber Cancer Institute
Dr. Kimberly Stegmaier is funded in part by a donation from the Rally Foundation for Childhood Cancer Research.
Alexandra Stevens, MD, 2022© Baylor College of Medicine
The Equity in Access Research Program aims to generate evidence that will guide changes in healthcare policy and practice to ensure that all blood cancer patients and survivors achieve access to the cancer care and services they need throughout their lives.
The Equity in Access Research Program is funded in part by donations from Amgen, Bristol Myers Squibb, GSK, Royalty Pharma and Takeda Oncology.
Stacie Dusetzina, PhD, 2022 Vanderbilt University Medical Center
Xu Ji, PhD, 2022© Emory University
F. Lennie Wong, PhD, 2022 Beckman Research Institute of City of Hope
Maria Figueroa, MD, 2023* University of Miami
Miguel-Angel Perales, MD, 2023* Memorial Sloan Kettering Cancer Center
Logan Spector, PhD, 2023*© University of Minnesota
Amit Verma, MD, 2023* Albert Einstein College of Medicine
Michael Keller, MD, 2022 Children’s Research Institute
Piers Patten, PhD, 2022 King’s College London
The Career Development Program (CDP) supports early career scientists and physician-scientists who are pursuing a career in blood cancer research. At the end of their funding period, awardees are evaluated for their most important contributions to the field, and those with the most impactful research are given a CDP Achievement Award (CAA).
Brandon Aubrey, PhD Massachusetts General Hospital
Jianjun Chen, PhD Beckman Research Institute of City of Hope
Noha Sharafeldin, MD, PhD The University of Alabama at Birmingham
Saad Usmani, MD, MBA, FACP Memorial Sloan Kettering Cancer Center
The LLS Excellence in Scientific Service award recognizes members of the scientific community who have had a profound impact on LLS by volunteering countless service hours to enhance the society’s ability to fund the best scientists and biotech companies.
Stephen M. Ansell, MD, PhD
Dorotha W. and Grant L. Sundquist Professor in Hematologic Malignancies Research
Mayo Clinic
Ronald Levy, MD
Robert K. and Helen K. Summy Professor in the School of Medicine and Professor of Medicine
Stanford University
Abintus Bio, Inc.
San Diego, CA
BioTheryX, Inc.
San Diego, CA
Caribou Biosciences, Inc. Berkeley, CA
Carisma Therapeutics, Inc. Philadelphia, PA
Constellation Pharmaceuticals, Inc.
Cambridge, MA
Dren Bio, Inc.
Foster City, CA
Faron Pharmaceuticals Oy
Turku, Finland
ImCheck Therapeutics SAS
Marseille, France
Immune-Onc Therapeutics, Inc.
Palo Alto, CA
C. Casey Cunningham, MD
Santé Ventures Chair
Francie Heller Arabesque Asset Management
Stephen Ansell, MD, PhD Mayo Clinic, Rochester
Philippe Armand, MD, PhD
Dana-Farber Cancer Institute
Asher Chanan-Khan, MD Mayo Clinic, Jacksonville
Madhav Dhodapkar, MBBS Emory University
Courtney DiNardo, MD The University of Texas MD Anderson Cancer Center
Giulio Draetta, MD, PhD The University of Texas MD Anderson Cancer Center
Ian Flinn, MD, PhD
Sarah Cannon Research Institute
Christopher Flowers, MD The University of Texas MD Anderson Cancer Center
Patrick J. Fortune, PhD, MBA Partners Healthcare Systems
Helen Heslop, MD Baylor College of Medicine
Steven Horwitz, MD Memorial Sloan Kettering Cancer Center
Tapan Kadia, MD The University of Texas MD Anderson Cancer Center
Laura S. Kaufman, PhD, DABT Private Consultant
Ross Levine, MD Memorial Sloan Kettering Cancer Center
Janice Gabrilove, MD Icahn School of Medicine at Mount Sinai Co-Chair
Jonathan D. Licht, MD University of Florida, Gainesville Co-Chair
Omar Abdel-Wahab, MD Memorial Sloan Kettering Cancer Center
Stephen Ansell, MD, PhD Mayo Clinic, Rochester
P. Leif Bergsagel, MD Mayo Clinic, Arizona
Ravi Bhatia, MD
The University of Alabama at Birmingham
Catherine Bollard, MD, MBChB Children’s Research Institute
S. Lori Brown, PhD, MPH
Former U.S. Food & Drug Administration, Investigations Branch
Immunitas Therapeutics, Inc.
Waltham, MA
Kymera Therapeutics Inc.
Cambridge, MA
NexImmune, Inc.
Gaithersburg, MD
OncoPep, Inc.
North Andover, MA
Ryvu Therapeutics SA
Krakow, Poland
Sutro Biopharma, Inc. San Francisco, CA
Travera, Inc. Medford, MA
X4 Pharmaceuticals, Inc.
Cambridge, MA
James Reddoch, PhD Royalty Pharma
Robert J. Rosen, JD Greyhawke Capital Advisors
Ronald Levy, MD Board of Trustees of the Leland Stanford Junior University
Frederick Locke, MD
H. Lee Moffitt Cancer Center & Research Institute
Ruben Mesa, MD The University of Texas Health Science Center at San Antonio
Vern Norviel, JD Wilson Sonsini Goodrich & Rosati
Susan O’Brien, MD University of California, Irvine
Daniel Pollyea, MD University of Colorado Denver, Anschutz Medical Campus
Steven T. Rosen, MD Beckman Research Institute of the City of Hope
Michael Savona, MD Vanderbilt University
Aaron Schimmer, MD, PhD
Princess Margaret Cancer Center University Health Network
Robert J. Spiegel, MD Spiegel Consulting LLC
Daniel Starcyznowski, PhD Cincinnati Children’s Hospital
Keith Stewart, MD
Princess Margaret Cancer Center, University Health Network
Sarah Tasian, MD Children’s Hospital of Philadelphia
Amit Verma, MD Albert Einstein College of Medicine
Renzo Canetta, MD
Former Bristol-Myers Squibb
Giulio Draetta, MD, PhD
The University of Texas MD
Anderson Cancer Center
Christopher Flowers, MD
The University of Texas MD
Anderson Cancer Center
Irene Ghobrial, MD
Dana-Farber Cancer Institute
Larry Kwak, MD Beckman Research Institute of the City of Hope
Ruben Mesa, MD The University of Texas Health Science Center at San Antonio
Susan O’Brien, MD
University of California, Irvine
David Weinstock, MD Dana-Farber Cancer Institute
We gratefully acknowledge the individuals, foundations and corporations that generously supported LLS’s mission during this fiscal year.
Pharmaceutical Funding Legend
PA Patient Access
PP Public Policy
R Research
C Campaign
* Denotes multi-year commitment
$1,000,000 and Above
Bristol Myers Squibb PA R C
Burlington
Gateway for Cancer Research
Genentech, Inc. PA PP C
Gilead Sciences, Inc. PA
GSK, formerly GlaxoSmithKline PA PP C
Hairy Cell Leukemia Foundation
Janssen Biotech PA
Kite, A Gilead Company PA PP C
Lisa Dean Moseley Foundation
Lyon Family Foundation
Norcross Foundation
Pharmacyclics, an AbbVie Company & Janssen Biotech PA PP C
Royalty Pharma
Takeda Oncology PA PP C
The Don & Lorraine Freeberg Foundation
The Harry T. Mangurian, Jr. Foundation
The Mark Foundation for Cancer Research
The Moore and Asma Families
The Paul G. Allen Family Foundation
Kym Rapier-Verette & Glenn Verette
Walgreens
Wawa
$500,000-$999,999
Bert Ogden Auto Group
Eli Lilly and Company PA PP C R
Horizon Therapeutics C
Institute for Follicular Lymphoma
Innovation
Jazz Pharmaceuticals PA C
Jersey Mike’s
Lang/Stiglitz Family Fund
Pfizer Inc. PA C
Subaru of America Inc.
The Lindenfelser Family Charitable Fund
$250,000-$499,999
Amgen, Inc. PA C
AstraZeneca Pharmaceuticals LP PA C
Barclays
BeiGene, Ltd. PA C
Jeff & Mindy Binder
Blue Cross & Blue Shield of Illinois
Ron Cohn
Elbit Systems of America
Summer Hall
Health Care Service Corporation
Higgins Family Charitable Foundation
Lisa Butler and David Holland, In memory of Maty Holland
James H. Reid, Jr. Beat AML Fund
Leukaemia Foundation
Norcross Family Foundation
Novartis Pharmaceuticals Corporation PA C
TC Oxley
Charles Schultz
Snowdome Foundation
The Bobby Zahurak Pediatric AML Research and Patient Support Fund
The Borstein Family Foundation
The Frederick A. DeLuca Foundation
The Marie Lamfrom Charitable Foundation
The Orokawa Foundation
The Terence J. O’Sullivan LIUNA
Charitable Foundation
Anita Zucker
$100,000-$249,000
AbbVie Inc. PA
ACE Family Foundation
AMSOIL Inc.
Bank of America
Colleen Barnhart
Dr. Evelyn Bata
BD
BDO USA, LLS
Builders FirstSource
Century Group Inc
Chesmar Homes Austin, LTD
Stephen K. Collins
Community Foundation
Consumer Portfolio Services, Inc.
Daiichi Sankyo Pharmaceutical
Company PA
John Doerr
EKC Enterprises, Inc
Enmark Stations, Inc.
Epizyme, Inc. C
F.M. Kirby Foundation
FIS Foundation Inc
Barbara & Gary Freedman
Hearst Foundations
Lara and Matthew Hjortsberg
Ronald Holten
Ibis Foundation of Arizona
IHOP
Incyte Corporation PA C
J.T. Tai & Co. Foundation, Inc.
Janssen Oncology & Legend
Biotech PA
Karyopharm Therapeutics PA C
KPMG LLP
James Lau
Amy and Gentry Lee
Paul and Maria Leinwand
James Liautaud
Lighthouse Investment Partners, LLC
Linda Tallen & David Paul Kane
Educational and Research Foundation
McKesson
Morgan Stanley
Nashville Wine Auction
National Christian Foundation
Richard & Debra Oliver
Opes Charitable Foundation, Inc.
Clyde McGregor and Lee Ann
Pederson-Pope
Pennsylvania Department of Health
PwC LLP
Ralph and Janice Shrader Fund
Regeneron Pharmaceuticals
Rhode Island Foundation
Robert J. Penta Foundation
Mike Royal
SAIC
Salt River Pima-Maricopa Indian Community
Larry and Sharon Saltzman
Schwab Chartiable
Seagen, Inc. PA C
Greg and Marcie Sinaiko
Summit Mortgage Corporation
Sylvester Comprehensive Cancer Center
TG Therapeutics PA
The Black Family Fund
The Harold & Helen Gottlieb
Charitable Foundation
The Jefferson Family C
haritable Foundation
The Peter DeGeorge
Charitable Trust
The Richard M. Schulze
Family Foundation
The Wawa Foundation
Larry Treen
Truenorth Energy, LLC
Trustar Bank
UCI Health Chao Family
Comprehensive Cancer Center
UCLA Health / Goldman Sachs
WellsFargo
West Pharmaceutical Services Inc.
World Wide Technology
Wrobel Family Foundation
$50,000-$99,999
ADC Therapeutics America, Inc. C
Alto-Shaam, Inc.
Amalfi Jets
Associated Bank
Autolus Therapeutics PA
BASF
Benchmark Bank & Benchmark Title
Bert W. Martin Foundation
Blackstone Charitable Foundation
Alan and Madeline Blinder
Blue Cross & Blue Shield
Blue Cross and Blue Shield of Kansas City
Blueprint Medicines Corp. PA C
Alex & Janet Boggs
Boise Cascade Company
Brasfield & Gorrie, LLC
Jim Broyles
Carolan Research Institute
CDPHP
Century Therapeutics C
Chase
Chemed Foundation
Community First Foundation
Compass Self Storage
CRISPR Therapeutics PA
Critical Start
Cross Country Healthcare, Inc.
CyKor
Dal’s Big Hands Big Heart Foundation
Dallas Promotions
Data Media Associates
Department of Finance Division of Treasury
Don Mealey Subaru Sport
Earl D. and Marian N. Olson Fund
El Bolillo Bakery
Ernst & Young, LLP
Fairway Independent Mortgage Corporation
Fidelity Brokerage Services LLC
Engelstad Foundation
GEICO
Generac Power Systems, Inc.
George Shields Foundation
Georgia Power Company
Glen E. Tullman Fund
Global Payments
Goldman Sachs & Co, LLC
Gordon Charter Foundation
Greater Sum Ventures
Guardant Health
Mr. and Mrs. David Hahn
Marla Persky and Craig Heberton
Hibbett City Gear
Highmark BCBS Delaware
BluePrints for the Community
Hildegarde D. Becher Foundation
Howard Family Foundation
ICON, plc
JE Dunn Construction
JLL
Kendra Scott, LLC
Kirkland & Ellis LLP
KLA Laboratories Inc.
Cheryl Korth
Kyowa Kirin, Inc C
Lehigh Valley Restaurant Group, Inc./ Red Robin
Lenoir Charitable Trust
Christopher Lim
Lowthers Family Foundation
Luppen Family Foundation
Williard Earl Lynn
Maine Cancer Foundation
Marge & Charles J. Schott
Foundation
Ilana Massi
Medical Properties Trust
Memorial Healthcare System
Merck & Company PA PP
Robert Merrick
Michael Sweig Foundation
MJH Life Sciences
Moffitt Cancer Center
MSC Industrial Supply Co.
Net Lease
Northside Hospital
Northwest Biotherapeutics
Ochsner Health System
OU Health
Paul Davis Foundation
Planned Systems International, Inc
Fred and Cherie Pond
Presidio
Price Family Foundation
PSCU
Kyle and Erin Ragsdale
Ray & Dagmar Dolby Fund
Rein Family Donor Advised Fund
Robert E. Gallagher Foundation
Melody & Rick Rogers
Lois and Jerry Rosenblum
Joan Rubschlager
Sana Biotechnology
Sarver Charitable Trust
Drew and Donna Schwartz
Bryan Schachter
Brian Shanahan
Silicon Valley Bank
So Long to Leukemia
Erika Steiner
Sutter Health I Aetna
Taiho Oncology Inc. PA
Tapestry
Ann Taylor
Mark Taylor
Texas Oncology
The Batchelor Foundation
The Boldt Family Philanthropy Fund
The Hand Family
The Jackson Family Charitable Fund
The Ken and Marlene Mack
Charitable Fund
The Louis M. Plansoen
Charitable Trust
The Ping Y. Tai Foundation, Inc.
The Tampa Bay Lightning
The Willard L. Eccles Foundation
Tito’s Handmade Vodka
Ken Trainer
Truist
Upswing Foundation
Vanguard
Byron & Laurie Vielehr
Drenda Vijuk
VyStar Credit Union
W.R. & Norma Ramsey Foundation
Chip & Sarah Wagner
Watermark Retirement Communities
WellMed
Wespac Construction
Dana White
Wilkinson Stekloff
William R. Rich Foundation
Yvette & Arthur Eder Charitable Foundation
Michael Zemke
$25,000-$49,999
512 Main Street Inc.
Aegon Transamerica Foundation
Airtower Networks
Akbaraly Foundation
Ak-Chin Indian Community
Akin, Gump, Strauss, Hauer & Feld, LLP
ALCO LIQUIDATING TRUST
Alex’s Lemonade Stand Foundation
Alice Kleberg Reynolds Meyer
Foundation
Allegis Group Foundation
Ally Financial Inc.
Alston Construction Company, Inc.
Margaret Anderson
Andre Agassi Foundation
Todd Andritsch
Anrak Corporation
Apex Imaging Services
ARMKAT, LLC
Arnold Ventures
Arrow Exterminators
Arvest Bank
Ashwood Construction
Astex Pharmaceuticals, Inc. C
AT&T
Audrey & Jack Harris, Megan Yowell
Oglesby & Hunter Oglesby and Seth & Sara Yowell
Daren Austin
Bank of America Charitable Foundation
Baptist Health South Florida
Joseph Baratta
Fred & Jana Bartlit
S. Bauer
Baylor Scott & White Health
Bellco Capital
Ben E. Keith Foods
John Bennett
Bloomberg LP
BNY Mellon
Jonathan Boggs
Dan & Paula Bongino
Bonnie L. Bolding Charitable Foundation
Dave & Kate Borowski
Breakthrough Properties Bellco
Buzy Family Fund
California Community Foundation
Shane Canestra
Cantor Fitzgerald Relief Fund Administration
Carlson Family Foundation
Carlton Hill Family Foundation
Carol Stuhr Family Foundation
CaseWare International
CBH Homes
Centennial Bank
Central California Housing
Charlotte Radiology
Chelsea Morrison Foundation
Chickasaw Nation Division of Commerce
Chick-fil-A
Cigna
Ciocca Dealerships
Circle City Foundation
Cisco Systems, Inc.
Citizens Bank
Citrix Systems, Inc.
Robert Clippard
Coca-Cola Consolidated
Richard Cole
Collabera Inc.
Community Health System
Complete Clothing Company
Cora and John H. Davis Foundation
Costco Wholesale
Creative Manufacturing Properties
Credera
Cronin Automotive
Cruise Planners
Joseph Cupoli
Thuy & Mitchell Dancik
Darlington Shredding Company
Dekko Investment Services
Dell Technologies
Deloitte
Delta Dental
Deltek, Inc.
Laura DeLuca MD
Diagnostic Centers of America
Dina & Andrew Wallach Foundation
Discount Drug Mart
DMI Personal Care
Gabriel & Cameron Dobbs
Dominion Energy
DORFMAN AND KAISH FAMILY FOUNDATION
Martha Dudley
Edith M. Schweckendieck Trust
Edward Jones
EFESTE
Elisabeth Severance Prentiss
Foundation
Enterprise Holdings Foundation
Eventbrite, Inc
EY
Patrice Fanning
Gary & Susan Farmer
Mike Farmer
Farmhouse Fraternity Association
Inc.
Federal Credit Union
Arash Ferdowsi
Fidelity
Fifth Generation, Inc./Love, Tito’s
Findlay Automotive
First Financial Bank
Fletcher Jones Motorcars
Florentine Camenisch Trust
Florida Blue
Sherry and Martin Franks
Steve & Phyllis Fridrich
Greg Friedman
Friendly Ford
FSI Engineering and Design, Inc.
Furniture Fair
Christopher Gaffney
GalaxE.Solutions, Inc.
Gamida Cell C
Mary Gangelhoff
Garber Management Group
Georgia Ports Authority
Giant Food
Grant Thornton LLP
Green Bay Packaging Inc
Eric Grossman
Mike & Ashley Guadagnini
GuidePoint Security
Guidewire
Mr. and Mrs. F. Robert Hall
Peter and Arlene Harman
Russell Harris
HCA Healthcare
HCA Midwest Health & Sarah
Cannon Cancer Center
Albon and Debbie Head
Helix Ventures
Paul Hellman
Heritatge Title
David Hitz
HM Insurance Group
Hudson Family Foundation
Ms. Lamar Hunt
Huntsman
John & Kristin Hyland
Imagine A Cure for Leukemia
Insight Global
IQVIA
Iron Bow Technologies
ISN
J. Edgar Monroe Foundation
James Hardie Building Products, Inc.
Jennifer and Jake Skuce Foundation
Craig Jensen
Jewish Community Foundation
Jim Turner Chevrolet
Joe & Jessie Crump Foundation
Josephine Johnson
Daniel & Susan Kane
Keerat Baweja Memorial Foundation
LLC
Keith Zars Pools LTD
Kenna Kunijo LLC
Richard and Gloria Kerns
KeyBank
Zak Khan
Jennifer Kipphut
Neil and Emily Kishter
Nicole Kline
Koppers, Inc.
Mark and Christine Kraemer
Kritchman Family Foundation
Ed and Fran Kuchar
Ed and Jennifer Kuchar
Lynn Kuckelman
Kumin Family Charitable Fund
Laborer District Union
Carolyn Levine
Lion Group Inc.
Andrew & Andrea Lipman
Vicki Logan
Lou Fusz Automotive Network, Inc
Roberta Lowell
Lowenstein Sandler LLP
LPL Financial
M.G. O’Neil Foundation
Michael Madoff
Robert & Emily Mahar
Malloy Toyota
Craig & Susan Manske
Marilyn Lichtman Foundation
Material Bank
Serena & Bryan Mattson
Greg McAfee
Drew McCandless
David & Joy McDaniel
Mark McLaughlin
Mears Group Inc
Memorial Sloan Kettering
Merchandise Pickup Service, Inc.
Kathleen Meriwether
MetroStar Systems
Miami Cancer Institute
Microsoft
Marcia & Mark Miller
William Miller
Minto Communities, LLC
Mitek USA, Inc.
Moksha Aesthetics
Monumental Sports & Entertainment Foundation
Morgan & Morgan
Morguard Management
Company, Inc.
MorphoSys US Inc. C
Morrison Foerster Foundation
Greg and Beth Myers
Nektar Therapeutics C
Bryan Nelson
Nelson Mullins
Nelson Mullins Riley &
Scarborough LLP
Anne Nelson-Debord
New York Presbyterian/Weill Cornell
Medical Center
Niagara Cares
Katrina Nietef-Wong
Nolan Transportation Group
North State Bank
Northrop Gruman Corporation
Northside Chevrolet
NOVA Home Loans
Nutrien
NYCB
Okafor Family Foundations
Javier Olivan
Olive
Edward Oluges
Optum
Orlando Health
Rick Ostroff
Ostroff Associates Inc
Tom Pang
Parexel
Parkview Health
Penn Medicine Development
Abramson Cancer Center of the University of Pennsylvania
Performance Automotive Network
Tracy and Julie Peters
PhRMA
Planet Fitness
Plantation Ford
Pledgeling Foundation
PNC
Art & Kathy Pope
Verna Porter Buxton
Pray Family Foundation
Pueblo, Inc
Quinn Emanuel Foundation
Rademacher FLP
Rambus
Raymond James
David Rendina
Richard and Terez Abatecola Foundation
Richard B. Siegel Foundation
Richmond County Savings Foundation
Riverside Homes
Robert F. Beard Charitable Foundation
Frederic Roebke
Rogers Family Foundation
Bob Rosen
Brian and Catie Ross
RSM US Foundation
Ruoff Mortgage
Ryan Foundation
David Ryle
Ryan Sabol
Jeff & Pat Sachs
Niki Salter
Pierce and Maggie Sandwith
Sarah Tarditi Gallagher Memorial
Fund
Frank Schmidbauer
Alexander Schultz
Schutte Foundation Trust E
Sehlke Consulting LLC
Servier Pharmaceuticals LLC C
Sevan Charitable Foundation
Sewell Automotive Companies
Jeff Shaw
Sidley Austin LLP
Sila Realty Trust
Jim and Janet Sinegal
Marietta Sirleaf
Smiles of Chevy Chase
Frederick Smith
Iris and Michael Smith
Lynda Smith & Family
Tanya and Dan Snyder
Solutionreach
Sonecha Family Foundation
St. Joseph’s/Candler Health
System-St. Joseph’s Hospital
State of Oklahoma
Steel Dynamics, Inc.
Rob Steigerwald
Don & Marilyn Steiner
Steve and Phyllis Fridrich Family
Advised Fund
Stifel Nicolaus
Stone Hill Winery
Stonelake Capital Holdings, LP
Deborah Sturges/Hallmark Home Mortgage
Cheryl Sucato
Suncoast Credit Union
Swedish Cancer Institute
Syndax Pharmaceuticals Inc. C
Roberta Taskar
Teammates For Kids Foundation
Thayer Clinical Psychology
Services LLC
The Beam Team
The Breeden-Adams Foundation
The Chaney Family Foundation
The Cheryl S. Barnes
Revocable Trust
The Columbus Foundation
The Enrichment Foundation
The Feit Family Fund
The Friese Foundation
The Good Works Corporation
The Handlery Foundation
The Howard Hughes Corporation
The ICEE Company
The James Cancer Hospital
The JEM Project Foundation
The John and Frances Beck Family Foundation
The John R. Oishei Foundation
The Lois and Richard England Family Foundation
The Marcus Foundation, Inc.
The McDaniel Family Charitable Fund
The Parker Group, Inc.
The Smith Family Charitable Foundation
The Stanley and Joyce Black Family Foundation
The Thomas & Agnes Carvel Foundation
The W. O’Neil Foundation, Inc
The West Endowment
Tishman Speyer
TLB Dealer Services
TLC Starfish Foundation
Peter Tortorella Tour De Court
Trainer Family Transamerica
Trevor Loughlin Foundation
TrueNorth
Tucson Subaru
Thomas and Barbara Turriff
Two River
U.S. Lumber
UBS Financial Services, Inc.
UFC (Ultimate Fighting Championship)
UFCW
Ultimate Kronos Group
UM Sylvester Comprehensive Cancer Center
UNC Health
United Nissan
University of Chicago
University of Chicago Medicine
Urgent Care 24/7
VCU Health System
Victoria Anne Timmis Steele Special Needs Trust
Vida Ventures, LLC.
Vira Insight
David Wallace
John Ward
Warmenhoven Family Foundation
WealthOne Charitable Foundation
David Weinstein
Ellie Weissberg
Mark Weissberg
Wells Fargo Clearning Services, LLC
Westcap Management LLC
Whiting-Turner Contracting Company
WorkForce Unlimited
Bill Young
Zest AI
ZS Associates
Irwin Zucker, In memory of Paula J. OlsonI
$10,000-$24,999
1889 Foundation
360MD
4 Wheel Parts
4B Resources, LP
99 Ranch Market’s Tawa
Charitable Foundation
A Spark of Hope
A&T Subaru
A.M. Ortega General Engineering
Contractor Inc.
ABA Management, LLC
Matthew Abbott
Sandy Abbott
Kashif Abdul-Rahman
ABFS
ABM Industries Inc.
Acacia Apothecary& Wellness
Academy District 20
Calstra Account
Acurx Pharmaceuticals, Inc. C
Ann Adams
Adele S. Bernett Memorial Fund
ADP Foundation
Advent Health Orlando
AEP Foundation
Aetna Inc.
AFLAC, Inc.
Ageless Men’s Health
Agentcor
Benny Agosto Jr
Ron Weiss & Peggy Ahlin
Raheel Ahmad
Donald Aicneeley
Akel Homes
Alair Homes
Carolyn & Andrew Albstein
Alchemy Technology Group
Alexandria Real Estate Equities, INC
Mr. and Mrs. Patrick Alia
Alice Ann Bien Memorial Foundation
Dean Allara
Allegheny Health Network
Ben Allen
Josh Allen
Matthew Allen
Allied Associates International
Allmond & Company LLC
Allogene Therapeutics PA
Rob and Molly Allred
Allstate
Ally Bank
altafiber
Gale Altman
Hortencia and Alfredo Amaya
Ameren Illinois
American Endowment Foundation
American Fuels & Petrochemical
Manufacturers
American Fundraising Foundation
American Systems
Ameriprise Financial Services, Inc.
AmerisourceBergen Services Corp.
Ames Construction
Ann Amicone
AML Construction
Christopher Ammann
Todd Amsdell
Andersen Windows & Doors
Bill Anderson Anderson LLC
Robert Annable
Annette & Theodore Lerner Family Foundation
Anser Advisory, LLC
Anton Rx LLC
AOW Constructions LLC
Katherine Applegate
Margaret Arakawa
Dana Arcana
Arch Oncology
Arena Energy Foundation
AREVO Group, Inc.
Nancy Armstrong
Philip Armstrong
Sarah Armstrong
Arnhold Foundation, Inc
Charles Arnold
Art and Irma Mandell Foundation
Arthur M Blank Family Foundation
Ascend Federal Credit Union
Ascension Saint Thomas
Associated Credit Union
Astellas Pharma Inc. PA
ATAS
Atlantic Health System
Atlantis Resort SPE Limited
Atreca, Inc.
Atrium Health
Aurora Innovations LLC
Bryan Austin
Avalon Bay Communities, Inc.
Jacee Avara
Avenue Fabricating Merit
Construction
Avera
Michael Avidon
Avison Young USA Inc.
Avnet
James and Laurie Axelrod
Bach Bros Hobart
Meredith Bagby
Paul Baits
Kimberly Baker
Baker Tilly US, LLP
Eric J. Balaguer, MD
Balanced Environments Inc./Hard
Surface Solutions
Ryan Balderson
Leroy Ball
Jolee Bancroft
Baptist Health Louisville
Cancer Care
Andrew Barbieri
Barings
Baron Family Foundation
Tedd and Traci Barr
Baths of America
Doug and Janet Baughman
Scott Baun
Bay Electric Co., Inc.
BayCare Health System
Bayer C BCM One, Inc.
Be Courageous
Beam Team
Beam Therapeutics C
Beaman Motor Company
Ethan Beard
Beauchamp Maleki Group
Kimberly Beck
Brad and Stacey Beckworth
Abigail & Hampton Beebe
John Beem
Russell Been
Bell
Benford Capital Partners, LLC
Jorge Benitez
Benjamin & Seema Pulier
Charitable Foundation, Inc.
Robert Bennett
Joseph Berkes
Elaine Berki
Berkshire Bank
Chris Berlow
Charlene Berman
Bernard McDonough Foundation
Paula Berry
Wayne and Sandra-Lynn Berson
Best Egg
Bettina Equities Management
BGE, Inc.
Amit Bhatt
Martin Bicknell
Bicknell Family Foundation
Bilbrey Construction Co.
Biologics Inc.
BioMed
Mike and Katherine Birck
Birdie Box
Scott Birkhead
Birmingham Independent
Insurance Agenda
Jennifer Biry
Linda Bjelland
Bruce Bjerke
Black & Veatch Holding Co
Blackwood Foundation-Taylor
Blackwood
BLG Trust
Charles Blocksidge
Blue Line Construction
Blue Wolf Capital Partners
BlueLinx Corporation
BlueSky Jets
Elizabeth Blunt
Boatsetter
Boatyard Restaurant
Bruce Bocina
Kevin Boland
Booz Allen Hamilton
BorgWarner, Inc.
Borrell Electric
Boston Properties
Don Bradley
Yancey Bradley
Bradley L. Goldberg
Family Foundation
Braman
Kira and Andrew Brandman
Brandon’s Bourbon Inc.
BRANDT
Lauren Brandt
Rosanne Brandt
Loretta Bready
Lylle Breier
Roberta Brenman
Sean & Cecilia Bresnan
Bridge Investment Group
Bridgestone Americas Tire Operations
Heather Brien
Briggs Equipment
Brighthouse Life Insurance Company of NY
Andrew & Cindy Brock
Derek Brock
Peter & Janice Brock
Robert Brockway
Jeffrey Brokish
Campbell Brown
Jordan Brown
Ruse Brown
Stephen Brown
Brown Kiely, LLP
BRRH Foundation
Elyse Brubaker
Brutzkus Gubner Rozansky
Seror Weber LLP
Bubbakoo Burritos
Jennifer Budreau
Building Controls and Services, Inc.
Bullhorn, Inc
Joseph and Mary Bundrant
Bungalow Scenic Studios
Kerry Burda
Burke Family Foundation
Burr & Forman LLP
Harold Burroughs
Tom Burt
Julie Buschman
Amanda and George Bush
Andrew G. Buxton
BVK
Dr. John & Laura Byrd
Byrider
C. Jay Moorhead Foundation
C.H. Robinson
C3 Energy, LLC
Caesars Enterprise Services LLC
Mike Caggiano
Cahill Gordon & Reindel LLP
Cambia Health Foundation
Camelback Subaru
Cameron Memorial Community Hospital
Camp Doublecreek
Canaparo Family Charitable Fund
Renzo Canetta
David Canfield
Canfor Southern Pine, Inc.
Stephen Cannon
Cantanzarite Family Foundation
Capital Bank
Capital Moving & Storage Co., Inc.
Capital One
Nick Capobianco
Michael Capone
Cardiovascular Group
CardWorks Servicing, LLC
Care Institute Group, Inc.
Carlin and Julie Adrianopoli of The Chicago Community Foundation
Carlton Fields PA
Juan Carrillo
Carrington Charitable Foundation
Carruth Foundation
Carlynn Cary
Casey’s General Store
Cassano Household
Nicholas Castellino
Daniel & Anna Castro
Graham Cathey
Catholic Community Foundation
CB&I Power, LLC
CBH III Investments LLC
CBIZ
CBRE, Inc
Cedars-Sinai
Celebrity Cruises Inc
Central Atlantic Toyota
Centric
Centura Health
CFI Delivery
Andy’s Challenge
Oliver Chan
Chao Siu Family Charitable Fund
Charitable Flex Fund
Charles Esten
Charles McMurray Co.
Charles Schwab
Mary Chenoweth
Harry Cheung
Chevy Chase Trust Company
Chiaramonte Construction Company
Chipotle Mexican Grill
Choate Construction Company
Choice Hotels International
Sid Chowdhary
CHS AFJROTC Parents Club
Racheal Churchill
CIBC
Cintas
Ciox Health
Circle K
Citibank
Citrin Cooperman & Company, LLP
Ronald Cizzon
John Clancy
Clarendon Flavors
Brenda Clark
James Clark
Jay and Susan Clark
Clark Construction Group, LLC
Carlos Marban & Lisa Clarke
Thomas & Leigh Cleaver
Cleveland Clinic
CM Constructors
Bob Cohen
Cohn Reznick
Neil & Lizzy Cole
Cole, Scott & Kissane P.A.
Bill and Sheila Colombo
Colourpop
Columbia Capital
Columbia Restaurant Group
Abagael Combs
Charles Combs
Comerica
Communities Foundation of Texas
Community First Credit Union
Community Hospital of the Monterey
Peninsula
Community State Bank
Compass
Compass Group NA
James Conforti
James Conley Jr
Robyn & Don Conlon
Jack and Eileen Connors
Conrad Shlum Charitable Trust
Consonus Rehab
ConvergeOne
Converze Media Group
Convey Health Solutions
Jeffrey Cook
Dan and JoAnne Coolidge
Justin & Amy Cop
Cordoba Corporation
Berthel Corey
Cornerstone Building Services Inc
Corporate Incentives
CoStar
Maura & Tim Costello
Costello Inc
Coupa Software
Courtney Knight Gaines Foundation
Covey Security
Robert Cox
Paul Craig
Crane Composites
Victor Crawford
Creative Planning
Todd and Whitney Creel
Crescent Lighting Solutions
Crest Ultrasonics Corp
CRIF
Cross Country Consulting
David Crow
Crow Holdings International
Rebecca Crowe
Jonathan Crowley
Mr. Brent Hagey & Ms. Nicollette
Crowley
Crown Studios
CSX Transportation
Cumberland Group
Kelly & Blake Cunningham
Cunningham Swaim
Brian Cuppett
Cushman & Wakefield
Roger Cusumano
CVLUX
CW Financial Services LLC
D Wilson Construction Co.
Bassil Dahiyat
Bill and Jane Dahlberg
Dairy Queen Grill & Chill
Dakkota Integrated Systems LLC
Dallas Stars Foundation
Michael Daly
Peter and Helene Dameris
David Damus
Randy & Deborah Daniel
Danny Addis
Bracken Darrell
DAT Freight & Analytics
Sheela Dattani
Ivan David
David S. Brown
Davis & Adams Construction Inc
Elaine Day
Dayton Children’s Hospital
Dayton Foundation
Deborah J Heitz and Shaw B
Wagener Family Fund
Steve DeCook
Deepwatch
Matthew and Deidre Kimble
Del Rey Avocado
Delaware Orthopaedic Specialists
John DeLoche
Deluxe
Dennis Nill Memorial Fund
Emily Derderian
Desert Institute for Spine Care
Susan DeVore
Dezer Development
Dickinson Cameron Construction
Matt Diener
Dignity Health
Jon and Angie Dimalanta
Discover
H E Dishman
Diversitech Corp
DLA Piper LLP
DLE Equipment Inc
Kathleen Domm
Donald & Carole Chaiken Foundation
Donald B. & Dorothy L. Stabler
Foundation
Donald Palmer Charitable
Foundation
General Donation
Donegal Insurance Group
Donley’s Construction
Taki Donovan
J. Anthony Downs
DPR Construction
Barbara Drake
Draper Aden Associates
DTS Provident Design Engineering
Laura du Pont
Dudley Family Foundation
Avery Duke
Brittney Duke
Duke Cancer Institute
Duke Family Foundation
Thomas and Barbara Dunham
Dunham Trust Co
Troy Dunmire
Linda H. Dupree
Dutch Bros. Coffee
Rusty & Bill Duvall/Lincoln Property Company
E. L. & Thelma Gaylord Foundation
Eagle Pharmaceuticals, Inc. C
Earl and Brenda Shapiro Foundation
Brandon Early
Eastdil Secured, LLC
Eastern Salt/Granite State Minerals
Eby-Brown
ECI/ West Coast USA Properties
Ed Morse Automotive Group
Edward Riley Bradley
Tony Ehinger
William Eisig
Jesse Eisner
Electric Supply
Elias, Genevieve, Georgianna Atol
Charitable Trust
Elizabeth McGeachin McKee Foundation
Ella B. Cleveland Trust
Ellen P. Kessler Foundation
Scott and Sabrina Ellis
Scott Ellyson
Embry Health
Edward Emerson
Emily Settle Fund
Emory Winship Cancer Institute
Empire Eye and Laser Center
Enchanted Forest of Decatur
Enerplus Resources (USA) Corporation
Paul Engelder
Engineer Sales Company
Engineering Partners, Inc.
Ken & Linda Englebert
Enterprise Holding, Inc.
Epic
ePlus
Equifax
ER Bradley’s Saloon
Ergon Foundation
Bridget Murray and Eric Narcisco
Eric Scherbarth Leukemia
Research Foundation
Paul & Kathryn Ernst
Wilson Ervin
ESa
Markus Espinoza
Estate of Anneliese Kerschke
Ethos Group Inc
E-Trade
EverChain LLC
Everstream Analytics
Allison Ewart
ExactCare Pharmacy
Expeditors International of Washington
Ear Eye
Dan Fachner
Fred Fagundes
Lloyd Fagundes
Robert Faktorow
Farmers Empire LLC
Faulkner Subaru
FedEx Ground
Edward Fein
Gillian and Jesse Fein Hertzberg
Felvis Foundation
Garry and Ginny Ferraris
Ferreira Construction Company
Ferreira Power West, LLC
Fiduciary Trust Company Int’l
John Fierer
Finaly General Contracting Corp
George Finley
Tracy & Kelly Finn
Mary Clare Finney
Firefighter’s First Credit Union
First Media
First National Bank
First Tech Credit Union
Fiserv
Monty Fisher
Thomas Fitzpatrick
Flamingo Charities Inc
Gail & Tom Flanigan
Florida Cancer Specialists
Florida Crystal Corporation
Chase Flott
Flow Automotive, Inc.
Darren Fogel
Foghorn Therapeutics
Folsom Point Charities
Forma Therapeutics, Inc.* C
Don Forsell
Fort McDowell Yavapai Nation
Eric Foss
Thomas Foundanon
Karl Foundation
Foundation Medicine, Inc. C
Jonathan Fox
Fox Corporate Services
FOX Family Foundation
Frampton Construction Company
Dianne Franco
Mark Frasier
Fred Hutchinson Cancer Center
Fresno Livestock Commission LLC
Fresno Truck Center
Friends of Katelyn
Lynnette Friess
Traci Friess-Clark
Frost
Fuel at Jewell Inc
Blake Fulenwilder
BARBARA FUSCHETTI
Gainbridge
Galen College of Nursing
Marcia Gallaher
Eduardo Gallo
Troy Gamble
Gamble & Company LLC
Meredith Gantcher
Melissa Ganzi
Victor Ganzi
Israel Garcia
Hamilton Garnsey
Connie and Mark Garrett
Kevin Garvy
Gary and Pennie Abramson
Charitable Foundation
Gary C Butler Family Foundation
Gas South
Carole Geballe Schnake and Adam Geballe
Joe Gebbia
GEHA
Angela Gelov
George & Liz McKinnon Foundation
George & Margaret McLane Foundation
George and Mary Josephine
Hamman Foundation
John Georges
Gerald Jones Auto Group
John Giampoli
Craig Gibbs
Jesse Giordano
GL Marketing
Julie Gleit
Glist Entertainment
GM Advisory Group
Rebecca Godchaux
Godwin’s Gatorland Inc
Jane Goei
Goldberg Weprin Finkel Goldstein
LLP
Golden Wings
Donald Goodman
James Goodwin
Gordon Industrial Supply Co.
Cory Gourley
GovSmart
Laura and Mike Grace
David and JoAnne Graham
Graton Resort
Virgina Graves
Rick Gray
Greater Kansas City Community Foundation
Greenberg Traurig
Greene County 4-H Livestock Clubs
Greenhill & Co., LLC
Greenstein Delorme & Luchs, P.C.
David Gregory
Mark Gregory
Gregory Greenberg Children’s Foundation
Greystar Development, LLC
Louise & Guy Griffeth
Lindsay Grimes
Anne Groh
Grossmont Healthcare District
David Grunenwald
GTCR LLC
Guggenheim Life and Annuity Co.
Gunster
Mik & Heidi Gusenius
Gustaf W. McIlhenny Foundation
Roger Guthrie
Guthrie Inc.
H3 Biomedicine
H8 Cancer Foundation
Tom and Jan Hablitzel
James Hacker
Dickson Hagan
Felix Hage
Angelina Hallick
Hallmark Housekeeping Services Inc.
Hampton Lumber
Eric Handa
Hands of Hope - The Foundation of Cancer & Hematology Centers of West Michigan
Todd HANNA
Hannoush Jewelers, Inc
Allison Hanslik
Haraden Family Foundation
Hard Rock Hotel & Casino
Averill Harkey
Harkins Builders Inc
Janet Harper
Shane Harpham
Christopher & Jennifer Harris
Harry S & Isabel C Cameron Foundation
Denise Hartmann
Harvard Maintenance, Inc.
Harvey Builders
Richard Haskins
Hatton Foundation
Raymond Haupt
Haymakers for Hope
Cornell Nelly Haynes Jr.
HB Wealth Management, LLC
HCL Technologies
Health Carousel
Health Foundation for Western & Central New York
HealthONE
James Healy
Hearst Media
James Heavener
HEB McAllen #590
Linda Hedderman
Jim Hedrick
Holly Heer
Sheila Heinze
Heisley Family Foundation
Helena and Tom Stokes Family Foundation
Francie Heller
Helm Community Services CO
Randy Henderson Henkels & McCoy, Inc.
Henri Landwirth and Family Donor
Advised Fund
Henrich Family Trust
Wanetta Henry
Ernest Herron
Christine Schumacher and Hal Hess
Mr. David and Mrs. Judy Hicks
David Higgins
Highland Park Village Marketing Group, LLC
Kerry Hilton
Hi-Lume Corporation
Fred Hines
Hixson Lumber Company
Hobart Wealth
Louis Hoch
Greg & Stacey Hodges
Paul and Karen Hoelscher
Kevin Hofmann
Holland & Knight
Aaron and Susan Hollander
Burt Holmes
Homrich Berg
Brendan Horgan
Hostetler Ranches, LLC
Matthew Howard
Hoxworth Blood Center
HSC Aquisition, LLC
Jeff Huber
Huber Engineered Woods
Nancy Hughes
Hughes Management Group
Hulk LLC
Humana
Hunt Family Foundation
Hunt Ventures
Roberta and Luis Huntington
Huntsman Cancer Institute
Niles and Ginger Hushka
Hyperion Partners
Hy-Vee
IBC Bank
IBERIABANK/First Horizon
IDI Consulting
IEI Technology USA Corporation
iHeart Media
Imangi Studios
Immudyne
ImmunoGen, Inc. PA C
In Honor of finding cures for MN Kids
In Memory of Iyla Shacklady
Fiesta Inc
Waymore Inc
Independent Trust Company
Infocenter.io Corporation
Insight Sourcing Group
Institute for Cancer Research
Investors Bank
IPA Foundation
Irby Construction Company
Isgro Pastries, Inc
IU Simon Comprehensive Cancer Center
J.W. Didado Electric
Jack Buncher Foundation
Jack Henry & Associates Inc.
Cole Jackson
Jackson Lewis P.C.
Jackson Walker LLP
Jacksonville Florida Yard
Jacobs Engineering
John Jakes
Rick James
James and Gayle Halperin Foundation
Janitronics
Brian Jaramillo
Jeannette and H. Peter Kriendler
Charitable Trust
Jefferson Bank
Tom & Virginia Jennaro
John Jennings
Jennings Air & Mechanical
Erik Jensen
Jerry Parins Cruise for Cancer Fund, a fund of the Greater Green Bay Community Foundation
Jim Ellis Family
Michael Jingoli
Jingoli Power
JLB General Agency LLC
JOGUE INCORPORATED
Jonathan John
John Newell Wade Foundation
Amy Johnson
Daniel & Cynthia Johnson
Diana and Murray Johnson
Kaelan Johnson
Stacey Johnson
Johnson Controls
Jon & Mindy Gray Family Foundation
Billy Jones
John Jones
Joseph & Catherine Johnson Family Foundation
Joseph and Mary Fleischacker
Family Foundation
Josephine Charitable Foundation
JPMorgan Chase
JSR Micro
Jural Couey Carter Trust
Justin Chueh and Pauline Shuen
K & D Management, LLC
K Machine Industrial Services
Matthew Kabaker
Kadilhen Foundation
Rita Cavanagh and Gerald Kafka
Kairos Government Affairs
Kirk Kaminsky
David Kamo
Jordan Kaplan
Lawrence Kaplan
Fares Kargar
Peter Karmanos, Jr
Jonathan and Tammy Karnes
Donald Karpinski
Kearney & Co
Keck USC
Keeler Motor Car Company
Dave and Annie Keffer
Shaun Kelleher
Kellwood Foundation
Ken Anderson & Associates
Craig Kennedy
Linda & Greg Kennedy
Douglas Kenny
Patrick Kenny
Carol Kerins
Ryan and Jessica Kerrigan
Toner Kersting
Kettering Cancer Care
Kevin and Robyn McCarty
Charitable Fund
Sarah Keymer
Christopher & Lindsay Keyser
Akbar Khan
Kichler Lighting
Kimray Inc.
Kindred Healthcare
Jim King
Wanda King
King & Spaulding LLP
Kinsley Ray 5K
Laura Kipphut
Rick and Michelle Kirby
Steven Kirz
Kathryn And Luke Kissam
Kivort Steel, Inc.
Klapach & Klapach, P.C.
Don Klein
Jonathan & Robin Klein
Margaret Klenzing
Rochelle Klutch
Denise Knierim
Koch Companies Community Fund
Kolache Factory Inc.
Kirk Konet
Koons Tysons Toyota
Koppers Railroad Structures
Kornegay Company LLC
Michael Kouyoumdjian
Charles Kriser
Krista & Bryce Horton
Lois Kroll
Frank J. and Mary E. Kruse
Anoop Kumar
Kura Oncology C
Kymera Therapeutics C
L & J Vanderham Dairy
Labor Works LLC
Roger LaBoube
Darryl & Ellen Laddin
Lahood Properties
Lainie’s Angels
LAND DESIGN CONSULTANTS, INC.
Landaas and Co LLC
Landsouth Design Studio
Tracy & Ben Lange
Langley Federal Credit Union
Trish Lanoha
Eraldo LaPietra
Andrew Larew
Lauren Lash
Latham & Watkins LLP
Laughlin-Beers Foundation
Lauren Lash Designs
Robert Lavina
Lawrence and Carleton Mowell Fund
Lazar Industries
James and Mary Lazzari
Amy Lee
Jerry Lee
Robert Len
Lenkersdorfer Inc.
LEO Construction Company
Leon S. Peters Foundation
Ellen Leritz
Ronald Levit
Levitsky-Zuckerman Family Fund
Lewis Giving Fund
William Lia
Lia Auto Group
Liberty Mutual Group Inc.
Life Vac LLC
Lift a Life Novak Family Foundation
Liljenquist & Beckstead of VA
Troy Link
Lion & Blue Bear Foundation
Lisa Bilotti Foundation
LAWRENCE LITWACK
Kevin and Tracey Litwin
Anna Liu
LJA Engineering
Three Llc
Kim Llewelyn
Amanda Lloyd
Mike & Wanda Lloyd
Locke Lord LLP
Lockton Companies LLC
Lon V Smith Foundation
Lorenzen Candle Co.
Mathew Lori
Lee & Trey Loughran
Larry and Janice Lowder
LP Building Solutions
Luca’s Ride For AML
Ludeman Insulation & Supply
Dick & Connie Luebke
Lawrence Lum
Lument
Yongbin Luo
David Luski
LYNDSI & MATT
M Fried
M&T Bank
M&T Bank Charitable Foundation
Mabel Foundation
Madera Real Estate Group
Mallinckrodt Pharmaceuticals C
Ellen Mamn
Beverly Mancebo
Margaret and Foster Madeley
Family Foundation
Marilyn & Larry Margolis
Mark T. Sheehan High School
MarketOne Builders, Inc.
Anthony Marnell IV
Marquee Homes, Inc.
Marsh & McLennan Ageny
Marsh Insurance
Lori Martin
Lucy Martin
Mary Lou’s Coffee
Marya Stansky Charitable Gift Fund
Masco Corporation
George Stephen Mason, Jr.
Masonite
Massey Services, Inc.
David Massimilla
MasTec
Masters Capital Management, LLC
Matson Navigation Company, Inc. & Subsidiaries
Maurice & Judi Falk Foundation
Sara Mayer
Mayer Brown LLP
Mayo Clinic
Mays Family Foundation
Shelley Mayse
David Mazzotta
Courtney Mccarthy
Michael McCarthy
Thomas McCarthy
MICHAEL MCCORKEL
Tammy McFarlan
Bailey Mcguire
Glenn McKenzie
McKinsey & Company
Edward & Stephanie McLaughlin
Allyson McMahon
McManamy Jackson Hollis LLC
Jennifer McNeil
William McNitt
Shari McNulty
Daniel and Debbie McQuary
MDC Richmond American Homes
MDC/Richmond American Homes Foundation
MDU Resources Foundation
Robert Mead
MEDHOST
Media Information Services, Inc.
MediRevv
MedPace
Medstar Shah MSO LLC
Lucas Meeker-Harry
MEI Pharma, Inc. C
April Meier
Joseph Meisner
Meltzer Group
Memorial Sloan Kettering Cancer Center
Mercedes Benz of The Woodlands
Mercedes-Benz of Coral Gables
Mercedes-Benz of Cutler Bay
Mercury Financial
Bronson Meredith
Jon Merksamer
Phillip and Caren Merrick
Merritt Companies
Methodist Healthcare Ministries
Metrie Inc.
Jennifer Metro
Jim Meyer
Lenore and Dale Meyer
Meyer Klein Group - Thrivent
MHC Kenworth
MI Windows and Doors LLC
Bob and Brenda Michaels
Michigan Insurance Company
Midstream Energy Partners
Mary Milbert
Charles and Tammy Miller
David and Alejandra Miller
Miller Pipeline Coporation
Brian Millham
Karen Millner
David Millsaps
Milo’s Tea Company, Inc.
Laurie and Nate Minc
Christina Minnis
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo
MJC & Associates
MM Finance, LLC
Modern Yachts LLC
Mohawk Insurance Services
Momma Has Goals LLC
Montefiore Medical
Center--Oncology
Monterey Private Capital Inc.
Moody Family Foundation
Charlie and Wendy Moore
Thomas Moore
Elizabeth Moran
Brett Morris
Thomas Morrison
Robert Morse
Teddy Morse
Moss Construction
George Moss Jr
Mother Murphy’s Labs, Inc.
MRM Foundation
Jenn Mueller
Patrick Mullaney
Frank Mungo, Jr.
Gail and Timothy Munzing
Murphey Candler Baseball Inc.
Bill Murski
David Mutnick
Mutual Group
National Financial Services LLC
National Grid
National Philanthropic Trust
Nationwide Legal, LLC
Natural Designs Landscaping
Swati Navani
Navarro Family Foundation
Marjie and Tom Nealon
NearShore Technology
Nebraska Medicine
Brian Nelsen
Joseph Netherland
Neuberger Berman
Nevada Community Foundation Inc.
New York Oncology Hematology
Charles Newman
Matt & Martha Newsom
Walter Newsom
NFI Industries
Nicholas A Caspero & Tomiko Va
Bradley Nicklin
Stephen Nimer, MD
Nix Patterson, LLP
Norris and Debra Bishton
Foundation
North Park Subaru
Northern Regional Hospital
Northern Trust
Northrop Grumman Charity
Custodial Account
Northshore Community Fdn
Norton Healthcare
Novant Health
Novartis Institutes for BioMedical
Research C
Nurix Therapeutics C
Nutrient
NV5
NVG Corporation
Oakwood Bank
Josh Obannon
Lynne & Greg O’Brien
Lynne O’Brien
Dolores O’Connell
John & Rhonda O’Donnell
Randy Oehrlein
Josh & Tina Oertli
OG&E
Ohio’s Electric Cooperatives
O’Keefe Lyons & Hynes, LLC
Shelby & Jeff Oksman
Jim O’Leary
Olive I & Eunice J Toussaint Family Foundation
Amanda Olson
Leslie Olson
Omaha Community Foundation
Omeros Corporation
Onco360
One Workplace
Brian ONeill
Open Lending
Optim Orthopedics
Optimize Rx
Oracle America, Inc.
Orca Biosystems Inc. C
Orthodynamics Company, Inc
Maura O’Sullivan
Linda Outlaw
Outlyr
John Owen
P&A Group
Pacific Service Credit Union
Paley Rothman
Cari Palmer
Chris Panczner
Papa Johns
Parallon Revenue Cycle Point
Solutions Division
Alan Parham
Max Parker
Parker Hannifin Corporation
Parkview Ortho Hospital
Parnassus Investments
Mary Parsons
Alissa & Justin Partee
Pascua Yaqui Tribal
Passion Growers
Milan Patel
Payal Patel
Patheon Pharmaceuticals Inc. C
PathGroup, Inc.
PatientPoint
Patriot General Engineering Inc.
Paul & Beryl Greetin Foundation
Paul Hastings LLP
Express Pay
Payden & Rygel
Amber Pearce
frank pechacek
Chris Pedersen
Marguerite Pelissier
Penn Medicine Center for Cellular
Immunotherapies
Arnold Penner
Pennsylvania Wireless Association Inc.
Robert J. Penta
Pentair Foundation
Pentwater Capital Management LP
Pershing LLC
Ronnie Pertnoy
Petillo Inc
Petros Homes
Josh Petry
Phase 2
Philadelphia Performing Arts Charter School
Pi Kappa Alpha Fraternity
Martha Picciao-Mazor
Pier 92 Restaurant Inc
William Pierce
Pike
Pinecrest Endowment Fund
Mandy Pinion
Pinkerton Foundation
Pinnacle Financial Partners
Craig Pisani
Robert Pisani
Michael Pitcher
Michael Pittman
Pittsburgh Financial Consultants
Pivot International, Inc.
Playa Bowls Princeton LLC
Plexus Capital
James Plutt
Pomeranz Household
Allison Pon
Pond Roofing Company Inc
David Porter
Talmage Porter
Erik Powell
Loutishia Powell
Powers Aquatics
Powerserve Int’l
PPD Inc
PRA Group, Inc.
Precision Biosciences, Inc. C
John Preston
Timothy Presutti
Priority Physicians PC
Professional Emergency Physicians
Progressive Design, Inc.
Prone Family Foundation
Prosperity Bank
PSIOG Digital Private Limited
Ron Pusey
PVH Corp.
Pye Barker
Qlik
Quality King
Dustin Qualls
Dan & Marilyn Quayle
R.G. Miller Engineers, Inc.
Rabbitt Whalen Family Foundation
Michael Raber
Ralph C. Wilson, JR. Foundation
Ralph Lauren Corporate Foundation
Rene Ram
Ramón Worthington Nicolas & Cantu, P.L.L.C.
rand* construction
Karen Rankin
Barbara Rapaport
Dr. Ben Mibab & Mr. David Ray
RBC Wealth Management
RBW Logistics
RE/MAX
Tim and Luanne Reagan
Real Estate One Charitable Foundation
Susan Reale
Red Robin
Red Rocks Church
Donna Reed
Reed Family Foundation
Refuel, Inc
Mark Regante
Andrea Reid
Reid Family Charitable Fund
Reily Foods Company
Relentless 5k
Reliant Energy Systems, Inc.
Renaissance Charitable Foundation
Marjorie Rendina
Rendina Healthcare Real Estate
Republic Bank
James Resnick
Restoration Management Company
Reynolds & Reynolds Associate Foundation
Reynolds & Reynolds Co
Meredith Rice
Rich Dalessandro Memorial 5K
Richard Squier Pallet, Inc.
Richard W. Stayner & Ronda D. Stayner, a donor Advised Fund of Renaissance Charitable Foundation
Jamie & Jennifer Riesterer
Cody Ritchie
Jay Rittberg
RLB Squared
RNC Industries LLC
Mike Roark
Roberts Oxygen Company, Inc.
Johnathan & Shannon Robertson
Ruth Robinson
Scott Robnett
Rock the Campus
Rockefeller Group
Rockford Construction
Bonnie and Sam Roditti
Rodrock Homes, LLC
Scott Roeder
Jesse Rogers
Vicki Rollins
ROMA Charitable Foundation
Nancy Romankiewicz
Patrick Ronan
Rosa Madera- Team Just Love
Rose Paving
Alexander Roth
Jennifer Roth
Mary Roth
Mary L. Rowan
Christina Rowland
RPM XConstruction LLC
RSM
RT Specialy
Rubenstein Charitable Fdn
Seth Rubin
Rubius Therapeutics C
Alex Ruiz
Randy Rushing
Russell Family Charitable Fund
Russell Reynolds Associates Inc.
William Paul Rutledge
Patrick Ryan
Michael J. Ryan, Jr.
Barbara & Robert Sablowsky
Sagis, PLLC
SailPoint Technologies
Salinas Valley Memorial Hospital
Salmo Investments LLC
Sam & Peg Johnson Family
Charitable Fund
Sam Swope Family Foundation Inc.
San Antonio Spirit
Sahil & Mana Sanghvi
Barbara Sass
Saunders Construction Inc
Savannah Vascular Institute
Alexandre Saverin
Savvy Enterprises
ScanSource
James and Sally Scapa
Arlene Schafer
Mark Scharfman
Steve Schaub
Nate Schermerhorn
Elizabeth Schlesinger
Liz Schlesinger
William and Nathalie Schmicker
Charyl Schroeder
Richard Schultze
Gerald Schultzmicrometl
Schusterman Foundation
Schutte Foundation 1959
Marvin & Donna Schwartz
Kevin Scott
Stacy Scott
Tim Scott
Samuel Scott, III
SCP Health
Scripps
Chris Scruggs
Kenny Braverman & Liz Sczudlo
Sea Salt & Sugar
Sears Contract, Inc.
Sebastian Positivity Foundation
Glen See
Doug and Ruthann Seely (in honor of Anna)
SEFCU
Selective Insurance
Sensiba San Fillippo
Peggy & Carl Sewell
Seyfarth Shaw LLP
Sgt Mark Antonowitsch Fdn
Faisal Shaikh
James Shanahan
Eddie Shea
Tom & Kathy Shea
Shell Oil Company
Wade Sherman
Harold Sheroff
Sam & Becky Sherstad
Sam Sherstad
David Shevsky
Shannon Shipley
Matthew Shirah
Margo Shoup
John Shumate
Bart Sichel
Sidney, Milton & Leoma Simon
Foundation
Michael Siegel
Susan Siekierski
Sierra Pacific Mortgage
Signature Bank
Jerome Silber
Al Silva
Alan Silver
Silver Lining Wealth Advisors
Kyle & Stacia Simmerman
Lauren & Robert Simmons
linda simmoons
Mike & Reid Simons
Stacy and Jason Simpson
Simpson Thacher & Bartlett LLP
Patricia & Richard Sinaiko
Joe Sinclair
Jasvinder Singh
Singleton Family Foundation
Dr. Brett T Brinker and Dr. Heather
A. Slay
Dona Smith
Douglas and Phyllis Smith
Iris Smith
Jenifer Smith
Jill Smith
Kathy Smith
Kiernan Smith
MC Smith
Nicole Smith
Richard and Novelle Smith
Smith & Associates
Peter Sniderman
Josh Snow
Snowflake
Sofinnova
Albert Sohn
James Solomon
South Denver Windustrial
Southern Rivers EMC
Spangler Subaru
Spartanburg County Foundation
Spaulding Medical LLC
Spectrum Health
Amy Spencer
Carol and Mark Spisak
SPM Foundation
Mark & Christy Sponseller
SquadLocker, Inc.
Square 22
St. John’s United Church of Christ
Kriss Stackhouse
Diane Stamatelatos
Danuel Stanger
Sean and Jen Stanton
Star One
Steel Dynamics, Inc./Structural Rail
Division
Steele Foundation
SteelFab, Inc.
Darren Steenhoek
Jennifer and John Stelly
Sterling
Peter and Sandy Stern
Chasity Stewart
STG Partners Merrill Lynch
Stock Yards Bank and Trust
Mona Carlton Stogner and Grey
Stogner
John and Jane Stoneman
Stonies Taphouse & Bistro
Strat Hotel Casino & Skypad
Stacey Stratton
Stream Realty Partners
Studios at Fischer
Riley & Sarah Stuebe
Kathy Stypula
Robert “Sully” Sullivan
William Sullivan
Sullivan & Cromwell LLP
Sumitomo Pharma Oncology
Summerwood Partners, LLC
Sunbelt Rentals
Daniel Sunderland
Super Herber Bros Foundation
Surack Family Foundation
Frank Surface
Susan Bogin
Gene Sykes
Synchrony
Synovus
Syros Pharmaceuticals, Inc. C
Taneja Family Foundation, Inc.
Tarlton & Sons, Inc.
Taylor Farms
TCWGlobal
Team Just Love
TECO Energy, Inc.
Katherine Tedrick
Tee Off Against Corp.
Guido Teichner
Tekton Research, Inc
Tennessee Oncology
Lee (Tepper) and Dorine (Real)
Tepper & Real
Terakeet
Terumo Blood and Cell Technologies
Texas Health
Texas Instruments
TGIG, LLC dba The Grove
Thalia and George Liberatos Foundation
the A Little Good, a fund of The Indianapolis Foundation
The Adam Puritz and Robin Neiterman Fund
The Alaska Community Foundation
The Almond Company
The Antibody Society Inc.
The Barry S. Sternlicht Foundation
The Bhojwani Family Charitable Fund
The Bill Bass Foundation
The Blackstone Group
The Blue Lagoon Foundation Inc.
The Brad Blumenfeld Family Foundation
The Chotin Foundation
The Correll Family Foundation
The Cutinho Family
The Darla Moore Foundation
The David Spence Cancer Foundation
The Dorsey & Whitney Foundation
The Edward G. & Kathryn E. Mader Foundaton
The Eli and Edythe Broad Foundation
The Elpis Foundation
The Ethel and Harry Reckson Foundation
The Fishel Company
The Garcia Companies
The Hawthorn Group, LC
The Hight Family
The Hirsch Family Foundation
The James Broyhill Foundation
The Journeys Group
The Kaplan Family Fund
The Kay Family Foundation
The Keene Family
The Kirby Smart Family Foundation
The Laverna Hahn Charitable Trust
The Luminescence Foundation, Inc
The Marsal Family Foundation
The Meridian Group
The Natori Company
The Nelson Company
The New England Patriots Foundation
The Oliver Family Foundation
The Ordan Family
The Papadopoulos Family Foundation
The Phyllis M. Coors Foundation in Memory of Maxine Hurt
The Pomponi Family
The Rachel Ray Foundation
The RAST Foundation
The Rhoda and David Chase Foundation
The Robert and Nancy Reiner Family Foundation
The Robert R Sprague Foundation
The Roderick Seward, Flossie Radcliffe and Helen M. Galloway Foundation Inc.
The Salah Foundation
The Sam J. Frankino Foundation
The Sandy Hill Foundation
The Seth and Stacey Blackman Charitable Fund
The Shack Sackler Foundation
The Shaw and Betty Walker Foundation
The Signorelli Company
The Spencer Company
The Stanley M. Marks Blood Cancer Research Fund
The Stephen M Sander Fdn Inc
The Szabo Family
The Thomas Spiegel Family Foundation
The UHV Fund
The University of Kansas Cancer Center
The Vinik Family Foundation
The Whicker Family Foundation
The William, Jeff, and Jennifer Gross
Family Foundation
The Woodall Family Charitable Fund
Theda Care
Theodore R. Meyer Charitable Gift
Account
Therigy, LLC
Therma-Tru Corp
Thermo Fisher Scientific
Bruce and Lyndell Thiessen
Thomas Jefferson University
Liam and Felicia Thornton
Thrivent Financial
TIAA
Tigerfight Foundation
David, Jennifer Chris and Diana Tilton
Kim Tindall
Tinker Street
Titan Advisors LLC
TJS CONSTRUCTION
Tony Cook and DCPG Memorial Fund
Michael Tooley
Tooley Oil Company
Towbin Motorcars
Tower Hill Insurance
Towne Properties Asset Mgmt Co
Tractor Supply Company
Beth Trammell
Trammell Crow Company
TransUnion, LLC
Gregory and Tamika Tremaglio
Tri Counties Bank
Troutman Pepper Hamilton Sanders
LLP
Trust Company of the South
Tullett Prebon Americas Holding
Suzan Tunder
Lori & Richard Turbe
Chad Turner
Turner Construction
Thomas Turriff
Erik Tutor
U.S. Bank
U.S. Charitable Gift Trust
U.S. Electrical Services Inc.
UAB Medicine
UAMS
UBS
UCHealth
UFP Inc.
Mindy Uhrlaub
UHS of Delaware, Inc.
Ullico Inc.
Unanet
UNC Lineberger Comprehensive Cancer Center
Uniform Firefighters Associati
Union Bank of California
United Health Care
University of Iowa Healthcare
University of Kentucky Markey
Cancer Center
University of Michigan Rogel
Cancer Center
University of Texas - Rio Grande
Valley
UPMC Pinnacle
UPS GENERAL SERVICE
Wade Upton
Michelle Urban
URL insurance group
V Fine Homes
Jeff Vacirca
James Valentic
Valero
Valley Children’s Hospital
Vanda Pharmaceuticals Inc. C
Vault Bill Pay
Vecellio Family Foundation, Inc.
Shannon Venable
Venable LLP
Venture First
Philip Verwey
Brad & Tiffany Vick
Lois Vick
Katy Vickery
Vinson & Elkins L.L.P.
Ann Vivell
Vivian Health, Inc.
Vivian L Smith Foundation
Vizient
Vogel Family Foundation INC
Landria Voigt
Vor Biopharma C
W. MI Biggby Advertising Group
Susan & Williiam Wagner
Michael Wahlstrom
Walentas Foundation Ltd
Iris Walker
Walker & Dunlop, LLC
Stephen Wall
Walmart
Freda Wang
Warburg Pincus
Greg Ward
Karen Warner
Washington Gas
Watson Wise Foundation
Michael Waxman
WBM Heritage Roofing Inc
Stephen Weber
Linda Webster
Jacqui Weigman
Dana Weinstein
Weiss Household
Shari & Marc Weissbach
Irving & Ann Weissman
Richard Wells Pratt
Charles Wert
Wesco Distribution, Inc.
Robert West
Westchester Prosthodontics
Westin Homes
Weyerhaeuser
Joe Wickman
Joel Wiegert
Willco Construction Company Inc.
Willdan Group Inc.
Beth Willett
William A. Hagan, Jr. Foundation
William H Kopke Jr., Inc.
William J. Shaw Family Foundation
Greg Williams
John Williford
Willoughby Construction
Willowbrook LLC
Wilson Sonsini Goodrich & Rosati
Windsor Fine Jewelers
Sam Winegrad
Wings Over Leukemia and Lymphoma
Inc.
Joseph Wire
Wisenbaker Builder Services
Wolcott Rivers Gates
Jerome Wood
Woods Foundation
Dave Wooster
Workscapes
Worldnet Inc.
Mason Wright
Jacky Wu
X4 Pharmaceuticals, Inc. C
X-Caliber Capital
Xencor, Inc
Keith Yandell
Daniel Yevcak
Chong Yi
David Young
Zalik Foundation Fund
Zangmeister Center
Shad Zapalac
Zapalac/Reed Construction
Andrew Zetterman
Zurich American Insurance Company
Joseph Zvesper
#LetUsTellerAboutTheCure
Abby, Arabella, and Emma’s Team
ABC: Abolish Blood Cancer
Nancy Adair
Emily Ahmed
Ainsley, Joelle, and Piper’s Team
Alexander Akel
Evelyn Akers
Tom Alban
Nicole Albstein
Sergio Alejo
All in for a Cure
ALL In The Family
Allegro 2021
Allen Wasinger Fundraising Team
Allie’s Team
Ally
Chris & Jill Ammann
Amy Johnson’s Campaign Team
Sunil Ancha
Bill Anderson
Karla Anderson
Andrei The Brave
Andrew Wallace LLS Team
Annali Leach’s Team
Anne’s Warriors
Michael Annessa
Answer 4 Cancer
Answer for Cancer
Holly Ashbrook
Logan Ashton
Casey Atwater
Sherrie Austin
Avery Knox and Marcus Miller’s Team
Justin Ayd
Borzou Azabdaftari
Cindy Bachicha
Shelby Badillo
Lauren Bailey
Madeline Baltz
Deirdre Bambrick
BAN Blood Cancer
Alicia Barahona
Audrey Batcheller
Bauer Power
Gurshaman Baweja
BC We Care
Katie Beckworth
BeePositive
John Bennett
Daniela Berlinski
Aleshia Berthel
Beta Chapter of Sigma Alpha
Epsilon
Randy Bilger
Kevin Bjerke
John Scott Black
Blackstone AMBBR 2022
Marcie Blanco
Blessed to Fight
Blood Bound
Bloomberg Fall
Christopher Bolio
Bonnie Dickey’s Team
David Borowski
Borzou Azabdaftari’s Campaign
Team
Maggie Boucher
Taylor Bousfield
Carrie Bradley
Melvin Bradley
Brady’s Battle
Mike Brannock
Brave for Brase
Brian Kozera’s Team
Bridge Investment Group
Bristol Myers Squibb
Bronwyn Vance
Brooklyn Blood Battlers
Connor Brown
Secelia Brown
Builders FirstSource
Building Hope
Bullpups Beat Cancer
Steve Burnett
Elaine Burrell
Katie Burris
Tom Burt
CALLING TO CURE from the 804
Ann Cameron
Cancel Cancer
CANCER CRUSADERS
Cancer Destroying Crew (the CDC)
Cancer Eradicators
Cancer Kickin’ Crew
Cancer Killers
Capital Bank
Charles Cariello
Caroline’s Cure Team
Juan Carrillo
Carter’s
Carver Porter’s Team
Lori Cavallo
CCF Cleveland Clinic
Matthew Chan
Sandra Chancey
Mark Chao
Charity Price’s Campaign Team
Charles Esten’s Team Addie
Charlie’s Angels
Chasing Cures 2.0
Chris Bolio’s Campaign Team
Chris Pero’s Fundraising Team
Christine Mills’ Campaign Team
Justin Chueh
Circle of Hope
Lehigh Valley Circle of Hope
Cisco Systems RTP
Corina Clark
Marty Clark
Coast to Coast Cures
Margaret Coats
Ilyse Cody
Zach Coggins, CRPC
Cole Williams’ Team
Colin Burda’s Team
Colin Fitzgibbons’ Team
Collabera
Robyn Collums
Columbia Kicks Cancer
Combat Cancer
Coming for Cancer
Compass Self Storage
ConCUREing Cancer
Ronda Conger
Megan Costa
Cousins For A Cure
EJ Cox
Henry Coy-Burt
Tanner Crane
Creel Family Philanthropies
Cross Country Healthcare
Tracy Croxen
Cruisitude for a Cure
Jennifer Culhane
Kelly Cunningham
Cureone
Curing Cancer Never Goes Out of Style
Tanya Curry
Carly Daigle
Daiichi Sankyo
Thuy Dancik
Dave Wooster’s Campaign Team
Deborah Sturges’ Team
Decade of Magic
Natasha del Barrio
Linda Delaney
Meghan Delaney
Delta Difference
Emily Derderian
Capri Dessecker
Maryanne Diaz
Bonnie Dickey
Courtney Dickey
Martin Dietrich
Dominion Energy
Julie Donaldson
Murry Donaldson
Double A Saves the Day
Driving Forward for a Cure
Halleigh Duff
Matthew Duffy
Chrissy Dunlap
Eagle Mission...Soaring Above Cancer
Eagles for the Cure
Eagles Soar For a Cure
Edith Brockway
Kenna Ehman
Eric Eissenstat
Elbit Systems of America
Elections Systems & Software
Ellie Payne’s Team
Ely Mendieta
EntrepreCURE’S
Joe Erwin
Markus Espinoza
Charles Esten
ETrain
EY
Craig Eyers
Dan Fachner
Faham Zakariaei
Michael Farmer
Fearless Fighters
Gillian Fein
Andrea Ferenchik
Fight Like Hell
Fight the Big C
Fight With All Your Might
Fighting for a Cure
Fin’s Superheros
FIS
Colin Fitzgibbons
Florida Power & Light
Natasha Fooman
For Eva
For the Lovette
Force of Nature
Tom Forman
Angela Frazier
Fresno Fighters
Allie Fujarski
Fundraising Flamingos
Carlen Funk
Tracey Gairing
Kevin Galko
Grant Ganzi
Richard Garber
Garber Automotive
Vicky Garcia
Courtney Gettings
Aryanna Gharanfoli
Rodrick Glass
Casey Gocel
Madison Godinho
Jeremy Goldstein
Got CUREage!
Leslie Gottfried
Gracelynn Hyman’s Team
Grant Schermerhorn’s Team
Rick Gray
Greater Bay Area Triathlon
Greater LA Cycle Tour2Cure 2022
Jordana Green
Ava Gregory
Andy Grier
Eric Grossman
Mike Guadagnini
Albert Guida
Wally Gundlach
Vince Guthrie
Jorge Gutierrez
Mark Hahn
Hailey Peykoff
Kristen Haire
Summer Hall
Sarah Hamilton
Nancy Hamlin
Kaylin Hammer
Hannah Bonbright’s Team
Deborah Harrington
Olivia Hart Panczner
Denise Hartmann
HCA Corporate
Jim Healy
Hearts for A Cure
Hearts for Hope
Abby Hegerfeld
Helping Hands
Heluva Good Hike!!
Jane Hennessy
Mike Hennessy
Mike Henninger
Nicholas Herrel
Jesse Hertzberg
Savannah Heskett Beck
Hikers4Life
Mark Hinkle
HLS for LLS
Matt Hohorst
Carlito Holt
Horizon Therapeutics
Tracy Howard
Xixi Hu
Nancy Hughes
Hunters For a Cure
Hunting Down Cancer
Patric Hyland
Conner Imbody
IQVIA
Leslie Isler
It’s In Our Blood 2022
Jacks or Better
Nate Jacobs
Jags Hunt For A Cure
Adeline Jansson
Jay Juffre
JB Strong
JCStrong Legacy
Brett Jenkins
Will Jenkins
Jenny Booyah and the Peachy Tribe
Jessica Slick’s Team
Tara Johns
Amy Johnson
Greg Johnson
Colleen Jones
Jeffrey Jones
Sarah Jordan
Josie’s Warriors
Julie Donaldson’s Campaign Team
Just a Mile to Go
Just Beat It
Just Cure It
Kaity Wachtel Team
Jimmy Kalogeropoulos
Kirk Kaminsky
Kancer Krusaders
Kacie Kane
Richard Kaniewski
Karen Puente’s Campaign Team
Karen Weekly’s Team
Brian Keck
Lindsay Keyser
Akbar Khan
Kickapoo
KickinCancer
KIEp FEITing
Eric King
Jim King
King Cares
Jennifer Kipphut
Laura Kipphut
Steven Kirz
Kiss Cancer Goodbye
Nate Klein
Nicole Kline
Lance Knez
Knights to the Rescue
Brian Kozera
Sean Kramer
Alex Krasnec
Krazies Krushing Cancer
Katie Kreiser
Elaine Krueger
Kuchars Kicking Out Cancer
Lynn Kuckelman
Stephanie Kuhlmann
Molly Kusma
Felix Laboy
Lucy Labruzzo
Lace Up for LLS
Meghan Lansing
Larry Lucchino
Alana Kay Latiolais
James Lau
Laura Lewis’ Campaign Team
Eric Layne
Kathy Leslie
Emily Lewis
Laura Lewis
Larry Lieberman
Lily Frakes
Lily Walton’s Team
Emily Lipman Mahar
Josh Lippman
Alex Lipsky
LLS CUREsaders 2022
LLSaints
Lindsay Lococo
Lokahi
Christopher Long
Brian Loughney
Love and Light
Rachel Loveless
Drew Lufkin
Luke Andritsch’s Team
Lymphomaniacs
Juliana MacTaggart
Rosa Madera
Madoff and Herz for Cancer Cures
Laura Maier
Makenna Silviera
Anita Malik
Mana Ohana
Becky Mancuso-Winding
Mariella’s Mission
Mark Hahn’s Team
Carol Markway
Christy Marsengill
Sarah Marshall
Lori Martin
Valerie Maslow
Jamie Mast
Jeff McClure
Betsy McCorkle
Julie McCormick
Roger McCoy
Katie McCurry
McKesson
Edward McLaughlin
Megan’s Mission for the Cure
Tony Mehrtash
Heath Melton
Jeff Meyer
Meza’s Maniacs
Miami Cure Mission
Michael Annessa’s Campaign Team
Mighty Mason’s Warriors
Karl Miller
Christine Mills
Moms In Training 2022
Josie Moreland
Andrew Morgan
Morgan Stanley
Sarina Moss
Bridget Murray
Erica Murray Donaldson
Greg and Beth Myers
Naomi Weaver’s Team
Natalie Warther’s Campaign Team
Gina Natoli
Rebecca Nazario
Adam Neary
Carolyn Neary
Michelle Nemeth
Martha Newsom
Matt Newsom
Bruce Newton
Allison Niday
Novant Health: Bond Beyond Blood
Matt O’Bryan
Ochsner Legacy Team
Friend of Chuck
Okafor Family Foundation
Haneen Omar
Ajith Pai
Pammy’s PACK
Valerie Parker
Kait Parrott
Parrott Pact
Amanda Paul
Kimberly Paulson
Pele’s Pirates
Rachel Peniche
Robert J. Penta
Amy Perlman
Chris Pero
Stephanie Perri
Pharmacyclics | Janssen
Lasondra Pontarelli
Pop’s Warriors
Michelle Porter
Ben Poyant
Nate Prather
Alex Price
Charity Price
Ross Prussin
Karen Puente
Racing for a Cure
Kyle Ragsdale
Catrina Ralston
Pankaj Ramani
Rampart High School
Paige Ramsey
Nayan Ranchhod
Richard Rayner
Rays of Hope
Charles Razook
Red Ribbon Raisers
Donna Reed
Leslie Reed
Regan Kosteck’s Team
Relentless for a Cure
Meredith Rice
Aimee Rich
Riders Of The Storm
Julia Riesterer
Maeva Riley
Jennifer Ristic
Robbie’s Rebels Against Cancer
Curtis Rocca
Rocco Pisani
Estee Roe
Martin Romanelli
Robert Rose
Sondra Rose
Mark Rubin
Rubin 4 Research
Janet Ruzich
Paul Ryan
Ryan Spahr Team
Rye for a Cure
Melissa Sacco
SAIC
Salesforce
Jeff Samuels
Joey Sanchez
Charlotte Sapir
Sarina Moss’ Team
Suma Satti
Trevor Sava
Savanna White
Mike Scanlan
Cody Scarboro
Bryan Schachter
Schardt on Cancer
Erika Schimmel-Guiles
Scott Schulman
Lindsey Schwartz
Richard Schwartz
Diana Jamail Schwarzlose
Helena Scott
Liz Sczudlo
SDG&E/Sempra
SeaGen
Secure the Cure
Peter Shankman
Kevin Shannahan
Mark Shannahan
Jeff Shaw
Tom & Kathy Shea
Grace & Jack Sherner
Natalie Sherod
Dave Shevsky
Charlotte Sigmund
Silicon Valley LavaTeam 2022
Al Silva
Mike & Reid Simons
April Sirleaf
Alan Skarbnik
Shelly Skidmore
Todd Slingerland
Clay Smith
Dona Jo Smith
Jason Smith
Korey Smith
Soaring For a Cure 4.0
Soaring For Hope
Brayden Sox
Ryan Spahr
Brandi Sparks
Jessica Spielvogel
Vivienne Spy
SqUAsh Cancer
Meredith St. Amour
Julie Stafford
Darren Steenhoek
Matthew Steindecker
Stephanie Perri’s Campaign
Clayton Stewart
Sticks for a Cure
Heather Stubblefield
Gala Stude
Deborah Sturges
Keri Suhy
Robert “Sully” Sullivan
Stuart Sullivan
Summit Mortgage Cancer Slayers
SuperHeroes Seeking a Cure
Survivor Strong
Suzannah Quayle
Jason Swift
Take to the Limit and Beyond
Scott Takinen
Holly Tancar
Brooke Teal
Team 007 License to Cure
TEAM 209
Team 4 The Cure
Team 4Coach
Team A(TL) Positive
Team ABCD
Team Adeline’s Allies
Team Albstein
Team aMaising
Team Ann Cameron
Team Austin’s Army
Team b.strong
Team Baking for a Cure
Team Banking on a Cure
Team Barbara’s Angels
Team BBC
Team Bears for a Cure
Team Believe
Team Believe in a Cure
Team Ben and The Cancer Kickers
Team Beverly and Kennedy
Team Bleeding Hope
Team Blood Blasters
Team Blood Busters
Team Blood Squashers
Team Blumenfeld Waterman
Team Brave Up
Team Breaking Good
Team Brightside
Team Bucket List Cure Cancer
Team Building For A Cure
Team Cancel Cancer
Team Cancer Combat Crew
Team Cancer Crusaders
Team Cancer Crushers
Team CANcer Not CANTcer
Team Cancer’s Kryptonite
Team Canes 4 the Cure
Team Capri D. Dessecker
Team Carlon and Sendaydiego
Team Cavs for Cures
Team Chaminade
Team Change Cancer’s Course
Team Charlotte Shares the Love
Team ChemoSabe
Team Children’s Cancer Crushers
Team Clayton Stewart
Team Close Cares
Team Connect For A Cure
Team Conor’s Crew
Team Conquer Cancer
Team CoUREage 3.0
Team Coy-Burt
Team Coyotes for a Cure 3.0
Team Cracking a Cure
Team Croga
Team CURE
Team CURE (Cancer Underestimated Raines & Emily)
Team Cure It!
Team CUREageous
Team Cure’em with Kindness
Team Curesaders
Team CUREsaders 2.0
Team Dancers Against Cancer
Team Dancers Cancel Cancer
Team Dancers Ending Blood Cancers
Team Danielle Chavez Trevino
Team Difference Makers
Team Dunaway
Team Ella
Team Emma Rose
Team Ensure a Cure
Team Ensure the Cure
Team E’s Angels
Team Faith Over Fear
Team Fearless
Team Fight for the Light
Team Fighting for a Cure
Team Fighting Irish Fighting Cancer 3.0
Team Footsteps of Faith
Team Foxes for a Cure
Team Fredericksburg Fighters
Team Gators Beat Blood Cancer
Team Get Aboard
Team Girls for a Cure
Team Gold 4.0
Team Good Vibes Save Lives
Team Grand Slam
Team Hayley & Katie
Team Hope
Team Hope Heals
Team Hope with Hoke
Team Hoyas for a Cure
Team ICEE Hope
Team Impact
Team In It to End It
Team Ironman
Team Jim Thorpe
Team Julia
Team Just Beat It!
Team Keeping the Faith
Team Kenna
Team Khanfidence
Team Kick Out Cancer
Team Kicking Cancer
Team Kipphut
Team KO Cancer
Team KPMG
Team Kramer
Team Kure for Kelly
Team Lance & Parker
Team Leukem
Team Life is Good!
Team Lindsay Lococo
Team Lioness
Team Lisa
Team Live Like Charlie
Team LLS Warriors
Team Lulu & Hardin
Team Lurking for a Cure
Team M.E.G.
Team Madnick
Team Maggie Boucher
Team Making Bank
Team May the Cure Be With You
Team MAYAmazing
Team MBA/Harpeth Hall
Team Mighty Muskies
Team Mission 1.8
Team Mission to Remission
Team Moffitt
Team N.E.D.
Team Newsom
Team One Team One Heart
Team OneinaPREMILlion
Team Out for Blood
Team Pack for a Cure
Team Panthers Against Cancer
Team Penta
Team Perlman
Team ProCURE
Team Rainbow Pony
Team Raise Hope Together
Team Raising Hope
Team Rally 2 Raise 4 a Cure
Team RamFam for a Cure
Team Ranchhod
Team Rays of Hope
Team Rebecca
Team Reed
Team Remission
Team Rende Strong
Team S.W.A.T. - Surry Working
Alongside Traci
Team S.W.A.T. 5.0
Team Saints for a Cure
Team Saving Lives One Mom at a
Time
Team Saving Our Youth
Team Secure the Cure
Team SF Bay
Team Shoot for a Cure
Team Silver Linings
Team Sister Strong
Team Sparks
Team Stand Up in Strongsville
Team Stangs for the Rangs
Team Steve Burnett
Team Strike Out Cancer
Team Stronger Together
Team Sully
Team Survive & Thrive
Team Survivor
Team Survivors for a Cure
Team Sutter Health
Team SWAG
Team Swarming Cancer
Team Takes a Village
Team Tapout Cancer
Team Tawny
Team Teal Six
Team Telescope
Team The Answer for Cancer
Team The Red Elephants
Team Tigers
Team Triumph
Team Tumornators
Team Ultimate Cancer Fighters
Team Uncover the Cure
Team Unstoppable
Team Will
Team Wish
Team Women On A Mission
Team Woodward Strong
Teens Tackling Cancer
Kerby Teller
Texas Instruments-Dallas
The Bloods
The Cancer Crushers
The Dream Team
The Howard Hughes Corporation
The IncredibLLS
The Lymphoma Leaders
The Pink Boa’s
The Z Machine
Throwing CUREballs
Tilden-Coil Constructors Team KSmo
Jay Tilley
Michael Tooley
Ken Trainer
Treat and Defeat
Treen Charitable Events Treen
Danielle Trevino
Triple Threat
UCLA Health
Jonathan Unger
United For A Cure
Until a Cure
Gustavo Valdespino
Danny Vance
Jill Vaughan
Kyle Verkouteren
India Vielehr
Jessica Visser
Andrea Voorhees
Kaity Wachtel
Mari-Michelle Wahlstrom
Walgreens
Jeremy Wallner
Wally Gundlach’s Team
Kendall Walsh
Cindy Walters
Warriors for a Cure
Natalie Warther
Allen Wasinger
Watermark Retirement Communities
Brad Watts
WE CANcer-vive
We Fight 4 To-Marrow
We WILL
Charlie Webber
Cindy Webster
Karen Weekly
Weez’s Warriors
Theo Weiman
Jessica Westlake Putrus
Whatever it Takes
White Out Blood Cancer 2 Liv
Gavin Williams
Dwayne Wilson
Joe Windler
Dave Wooster
Erin Zammett Ruddy
Zan’s Fans
Ashley Zeldin
Autumn Ziemba-McKenzie
Anita Zucker
Legacy Circle honors those who designate LLS as a beneficiary of their will, trust, retirement account or insurance policy, or fund a charitable gift annuity. We list our newest members below along with those whose bequests of $10,000 or more were received this year. .
Linda Amerling*
Stephanie Arnold in memory of Stephen J. Arnold
Lynn Aspey
Stacy and Nicki Auman
Jerry Baber*
Betty Mae Baker*
J. Leiter Bamberger*
Ellen Barone*
Audrey Barrett*
James A. Beck
Curtis Behr*
Rosie Bethke
James Carll*
Margaret Carson*
Brenda Cheney
Shawn and Elizabeth Clink
Stephen K. Collins
Melissa Tsaggaris Corso
Karen Crain*
Bettye Cruse*
Charles Cuda
Lauren Rosenberg and Matt Dabrowski
Andrew Dale
Peter Day*
Loretta DiRienzo*
Peggy and Margaret Dupaquier*
Harriet Dworetz*
Ken Epstein
Stephanie Estreen*
Ehenborg Family Trust*
Beth Farishon*
Thomas Fitzpatrick
Marion Ford*
Cindy Furst*
Laura Galbraith*
William and Donalda Gibson in honor of Stephen William Gibson
Scott Gildea in memory of Kayla Yearwood
Linda M. Glover in memory of James
Joseph Roberts
Jeffrey and Judy Greenhouse
Dan and Debbie Hempy
Rose Heminghaus*
Lara and Matthew Hjortsberg
James Hobbs*
Jeanne Hubbard and John Hubbard, PhD, FCP
Richard Hughes*
Thomas Jacobson*
Suryama Joshi
Ivan Kampel* Carol Kato*
Susan Keisling*
John Kellenyi*
Lisa Pelletier Kennedy in memory of Joseph Pelletier and Kaylee Carew
John and Catherine Kennedy*
Jacqueline Kent*
Wanda Kuntz*
Marjorie Lackey*
Norma Laine*
Elinore Lambert*
Betty Landeck*
Sharon Lessard*
Morris z”l and Zita Liebermensch
Richard Lieboff*
Robert Lindholm
Brad and Marcie Lontz
Salvatore Lucchese*
Margaret MacMurray*
Evelyn Maher*
Orlene Makinson*
Richard Millich*
Brad and Ellen Molotsky Foundation
Elizabeth Muldoon*
Louis Naumann*
Jeffrey and Paula Nelson
Sylvia Novick*
Margaret Olmazu*
Larry Olson*
Pam Olson*
Emily Papapietro*
Jeffrey Pollock
Fred and Cherie Pond
Jeffrey Quan*
Antoinette Ranalli*
Donald Rassaert*
Judy Redpath in memory of
Raymond L. Lippman
J. Landon Reeve*
Brian and Catie Ross
Mark Royer*
Rosalinde Russell*
Jenna Sager in memory of Shirley Holland
Angelena Sakalay*
Robert Sanders*
Jeffrey Schiff*
Gail Secrist*
Marianne Seidenberger*
Bruno and Irma Selmi*
Harold Sheroff*
Jay Silver
Greg and Marcie Sinaiko
Michael Smith*
Robert Snincak*
Anna May Snyder*
Scott Souba*
Mark Steburg in memory of Mia Steburg
Suzanne Strothkamp in memory of Harry M. Boyko, Jr.
Steve Stumbris
Zac Talmadge
Tim and Teresa Tanner in honor of Kayla Bradley
Herbert Vonderheide*
Theodore Weber*
Paul Webskowski*
Ruth Widmer*
Max and Joyce Wildman*
Christiane Roussell and Jabari Willis
Marvin Wolf*
Robert Wolfe*
Laurene Young*
Michael Zemke*
Anonymous (37)
* Deceased
Volunteers serve on our National Board of Directors providing leadership and governance to help find blood cancer cures.
Jeff Sachs Duluth, GA
Kathleen Meriwether Philadelphia, PA
Freda Wang Goldman Sachs Charlotte, NC
Ruben Mesa, MD, FACP Mays Cancer Center San Antonio, TX
Richard Bagger Westfield, NJ
Michele Cameron Allianz Global Investors US New York, NY
Renzo Canetta, MD Madison, CT
Casey Cunningham, MD Sante Ventures Houston, TX
Christopher Flowers, MD MD Anderson Cancer Center
Houston, TX
Janice L. Gabrilove, MD.
Icahn School of Medicine at Mt. Sinai New York, NY
John Greene Vineti
San Raphael, CA
Francie Heller
Arabesque Asset Management Greeenwich, CT
Lynne F. O’Brien McLean, VA
Marla Persky WOMN LLC
Ridgefield, CT Jim Reddoch, PhD Royalty Pharma Rye, NY
Richard Rendina Rendina Healthcare Real Estate Jupiter, FL
Robert Rosen Greyhawke Capital Advisors LLC West Palm Beach, FL
Bart Sichel New Hope, PA
Alessandra Tocco New York, NY
Louis J. DeGennaro, PhD
President & Chief Executive Officer
Troy Dunmire
Executive Vice President
Chief Operating Officer
JR Miller
Executive Vice President Chief Financial Officer
Gwen Nichols, MD
Executive Vice President Chief Medical Officer
Dale Nissenbaum
Executive Vice President
General Counsel & Chief of People
www.LLS.org/chapterfind
Susan Goss Brown SVP, Chief Diversity, Equity & Inclusion Officer - Field Development
Bernard Arthur VP, Field - Field Development
Jennifer Marley Chair, LLSC
Andrea Freeman
Northeast Territory Executive Director - Field Development
Dee Dee Hines
West Territory Executive Director - Field Development
Liz Klug
Central Territory Executive Director - Field Development
Piper Medcalf
Southeast Territory Executive Director - Field Development
Central Valley
Debbie Truhett
Connecticut/Up NY
Lori Glowacki
Desert
Laurie Susie
Eastern Great Lakes
Tina Massari-Thompson
Eastern PA/Delaware
Lauren Iannucci
Georgia/South Carolina
Amanda Yancey
Greater Los Angeles
Shannon Sullivan
Gulf Coast
Billie Sue Parris
Illinois
Breana Shawver
Lower Plains
Michelle Weigel
Metro New York
Andrea Freeman
Michigan/Indiana
Lori Morrison
Mid-Atlantic
Ria Freydberg
Mountain
Kristen Anderson
New England
Tara Greeley
New Jersey
Jana Boyer
North Carolina/Virginia
Emily Blust
North Florida
Melanie Johnson
Northern California
Sarah Clark
Ohio River Valley
Tom Carleton
Pacific Northwest
Katie Bolton
Red River
Leah Swanson
South Central Texas
Clarissa Flores
South Florida
Bobbie Jo Bates
Southern California/HI
Kathlene Seymour
Tennessee/Alabama
Jeff Parsley
Upper Plains
Kortney Hamm
The mission of The Leukemia & Lymphoma Society (LLS) is to cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. Find out more at www.LLS.org
